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Abstract
Predicting risks of chronic diseases has become increasingly important in
clinical practice. When a prediction model is developed in a given source cohort,
there is often a great interest to apply the model to other cohorts. However,
due to potential discrepancy in baseline disease incidences between different co-
horts and shifts in patient composition, the risk predicted by the original model
often under- or over-estimates the risk in the new cohort. The remedy of such
a poorly calibrated prediction is needed for proper medical decision-making.
In this article, we assume the relative risks of predictors are the same between
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the two cohorts, and propose a novel weighted estimating equation approach to
re-calibrating the projected risk for the targeted population through updating
the baseline risk. The recalibration leverages the knowledge about the overall
survival probabilities for the disease of interest and competing events, and the
summary information of risk factors from the targeted population. The pro-
posed re-calibrated risk estimators gain efficiency if the risk factor distributions
are the same for both the source and target cohorts, and are robust with little
bias if they differ. We establish the consistency and asymptotic normality of
the proposed estimators. Extensive simulation studies demonstrate that the
proposed estimators perform very well in terms of robustness and efficiency
in finite samples. A real data application to colorectal cancer risk prediction
also illustrates that the proposed method can be used in practice for model
recalibration.
Keywords: Absolute risk; Baseline hazard function; Calibration; Composite disease-
free probability; Cox model; Empirical likelihood; External generalizability; Risk
prediction.
1 INTRODUCTION
Accurate individual risk prediction for disease occurrence and progression is critical in
clinical decision-making to identify high-risk patients that need medical intervention
while preventing unnecessary treatment of low-risk patients (Alba et al., 2017). An
important aspect of predictive model assessment is calibration, i.e., the agreement
between predicted risks and observed outcomes of the target population (Steyerberg
et al., 2010). Ideally, the cohort used for model development reflects well the target
population to which the model will be applied. It can then be expected that the
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predicted risk will be calibrated well to the observed risk of the target population.
However, this is seldom the case. In practice, the data used for model building are
often from a clinical trial or research cohort that is assembled for specific purposes.
Due to self-selection and inclusion/exclusion criteria, the risk profiles of study par-
ticipants may not represent that of the population from which they are sampled. In
other situations, researchers may be interested in applying an established risk predic-
tion model developed for the general population to their own cohort of patients with
possibly different risk profiles from the general population. When not all the risk
factors are included in the risk prediction model because they are unknown or not
collected, the model can not be generalized across cohorts. Consider a hypothetical
example. Suppose the Charlson comorbidity index, a summary measure of various
comorbidities, is an important risk factor but has not been included in the risk pre-
diction model for a clinical outcome. Further the model is built in a healthy cohort
with on average a lower Charlson comorbidity index than the general population. As
expected, the baseline risk obtained from the healthy cohort would be lower than the
general population. Thus if one naively applies this model to the general population,
it can lead to an under-estimation of risk.
The poor calibration of prediction models across cohorts occurs frequently for
many disease risk prediction models. For example, Collins and Altman (2009, 2010,
2012) evaluated a series of models for predicting 10-year cardiovascular disease in sev-
eral independent United Kingdom (UK) cohorts of patients and found that the Fram-
ingham cardiovascular model over-estimated the risk, especially in men; Hippisley-
Cox et al. (2013) observed the Framingham stroke score under-predicted stroke risk
in UK patients; Abbasi et al. (2012) validated 12 prediction models for the risk of
developing type 2 diabetes over 7.5 years and found most of them over-estimated
the observed risk of diabetes, particularly at higher observed risks; recently, Drost
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et al. (2019) assessed two risk calculators for prostate cancer progression in five ac-
tive surveillance cohorts, and found one calculator over- or under-estimated risks in
two cohorts, and the other calculator over-estimated risks in most of the cohorts.
These diverse examples show that there is a substantial heterogeneity among cohorts
and insufficient calibration is common. Therefore, re-calibration of a risk prediction
model before applying it to the target population is critically needed for accurate risk
projection but is frequently under-appreciated (Van Calster and Vickers, 2015).
Estimating disease risk involves two components: the baseline risk and relative
risks of risk factors. Suppose T is the time-to-event and Z a p × 1 vector of risk
factors. Under the Cox proportional hazards model, the probability of developing the
disease before t1 given being disease-free at t0 in the absence of competing risks can
be expressed as
Pr(t0 ≤ T < t1|T ≥ t0,Z) = 1− exp[{Λ0(t0)− Λ0(t1)} exp(βT0Z)], (1)
where Λ0(t) is cumulative baseline hazard function and exp (β0) are the hazard ratios
of Z. As the risk prediction is for the target cohort, ideally both parameters β0
and Λ0(t) should represent the target population. When the parameter estimates are
obtained from a source cohort that differs from the target population, they may not
represent well the target population and need to be recalibrated. It is common to
assume that β0 is generalizable from the source cohort to the target population, as
Keiding and Louis (2016) noted that conditional features or distributions are more
likely to be “transportable” from one population to another than are marginal dis-
tributions. However, Λ0(t) can be quite different between the source cohort and the
target population as demonstrated in the above examples. Since disease risk involves
both β0 and Λ0(t), this poses a major challenge when applying a risk prediction model
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developed in one cohort to another.
To re-calibrate the baseline hazard function, the most direct approach is to refit
the prediction model using data from the targeted cohort. However, individual-level
cohort data linking predictors to the outcome are usually not readily available, partic-
ularly for rare diseases such as cancer. Assembling a cohort for rare diseases requires
an extended follow-up of a large number of individuals with detailed risk factor infor-
mation, which can be prohibitive in logistics and cost. In contrast, summary informa-
tion such as age-specific disease incidence rates and summary statistics (e.g., mean
and prevalence) of aspects of patient characteristics is often available from disease
registries, historical patient data, census data, and population-based survey data. A
more practical solution for re-calibration is to leverage this aggregated information
from the target population together with the individual level data of source cohort.
Leveraging summary information on disease incidence rates has been proposed
for obtaining the baseline hazard function (Gail et al., 1989; Liu et al., 2014). These
approaches require the joint distribution of all risk factors f(Z) to be common be-
tween the source cohort and the population from which the disease incidence rates
are obtained. However, this assumption is strong and often violated in practice. For
example, in our real data application, many of the risk factors have very different fre-
quencies across cohorts (Table 3 in Section 6). To relax this assumption, Chen et al.
(2006) obtained f(Z) = f(Z1,Z2) through combining the partial distribution f(Z1)
from the target cohort and f(Z2|Z1) from the source cohort, however still assuming
the conditional distribution is same in the two populations. This approach requires
individual-level data on Z1 from the target population. Therefore existing methods
are limited in their assumptions on the covariate distributions and the requirement for
individual level data from the target cohort when such assumptions are unjustified.
In this article, we propose a novel method to re-calibrate the baseline hazard
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function for the target population, leveraging only the summary-level information
without the need for a reference sample from the target population. Specifically, we
propose an estimating equation for Λ0(t) such that the overall disease probability is
constrained to be the same as that for the target cohort. To relax the assumption that
the joint or conditional covariate distributions need to be the same between cohorts
as in the existing methods (Gail et al., 1989; Chen et al., 2006), we propose to further
re-weigh the contribution of each individual from the source cohort in the estimating
equation. This effectively shifts the observed distribution of the source population
towards the target population and makes the sample more representative of the target
population. Without using individual level data, we propose to identify the weights
based on an empirical likelihood approach (Owen, 1988, 2001; Qin and Lawless, 1994).
We note that such a technique has been considered in the literature, for example,
to improve the efficiency of parameter estimation (e.g., regression coefficients) by
considering data sources external to the study (Chatterjee et al., 2016; Huang et al.,
2016; Han and Lawless, 2019). We adapt it here in the setting of correcting for
bias due to difference in covariate distributions. By solving the weighted estimating
equation, we obtain an estimator that gains substantial efficiency if the risk factor
distributions are same for the two populations, and reduces the bias considerably
when they differ. Finally, as the event of interest is often subject to competing
risks, we extend our method allowing the individuals to fail from multiple events and
provide a more accurate and practical solution to projecting absolute risk. To our
knowledge, this is the first work to recalibrate the baseline hazard function and thus
risk prediction in survival analysis for the target population with only the summary
information.
The rest of this article is organized as follows. We describe the proposed estimation
procedure in Section 2 and the large sample properties in Section 3. In Section 4
6
we extend the method for absolute risk when the competing risk is present. We
evaluate the finite sample performance of the proposed estimator through extensive
simulation studies, with the results presented in Section 5. We illustrate the proposed
method by an application to re-calibrate a risk prediction model for colorectal cancer
developed in the Womens Health Initiative (WHI) study (Womens Health Initiative
Study Group, 1998) as the source cohort to five different cohorts from the Prostate,
Lung, Colorectal and Ovarian Trial (PLCO) study (Prorok et al., 2000) and the UK
Biobank (Sudlow et al., 2015) in Section 6. Some concluding remarks are given in
Section 7. Technical details and additional simulation results are provided in the
Web-based Supplementary Materials.
2 METHODS
2.1 Notation and Models
Consider a source study in which a risk prediction model is developed for the time
to the event of interest, T , given a p × 1 vector of risk factors Z. We denote the
underlying population for this study by P ∗, and refer Pr∗ and E∗ generically as the
probability and expectation of random variables with respect to P ∗. The interest
is to generalize this risk prediction model to a target population P , for which the
corresponding probability and expectation are denoted by Pr and E, respectively.
We assume that individual-level data are only available for P ∗, but for P only some
summary information such as overall disease incidence rates and/or mean values of
some risk factors.
For both populations, we postulate the Cox proportional hazards model (Cox,
1972) for the relationship between the failure time T and the risk factors Z. Specifi-
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cally, for the source population P ∗,
λ∗(t|Z) = λ∗0(t) exp(βT0Z), (2)
where λ∗(t|Z) = limdt→0 Pr∗(t < T < t + dt|T ≥ t,Z)/dt, λ∗0(t) is an unspecified
baseline hazard function for P ∗, and exp(β0) is a p × 1 vector of hazard ratio pa-
rameters. Following the convention, we assume the hazard ratios for Z are common
between the two populations. Then for the target population P , we have
λ(t|Z) = λ0(t) exp(βT0Z), (3)
where λ(t|Z) = limdt→0 Pr(t < T < t + dt|T ≥ t,Z)/dt and λ0(t) is an unspecified
baseline hazard function for P . Note that no assumption is made about f(Z) being
same for the two populations.
For the source study from which the model is developed, let Ti, Li, and Ci be
the failure time, the left truncation time (e.g., study entry), and the right censor-
ing time for the ith (i = 1, ..., n) subject, respectively. Let Zi be a p × 1 vector of
risk factors in the prediction model. Define Xi = min(Ti, Ci) if Xi ≥ Li, and the
disease indicator δi = I(Li < Ti ≤ Ci), where I(·) is an indicator function. There-
fore δi = 1 if the failure time is observed and δi = 0 otherwise. We assume that
{(Xi, δi,Zi), i = 1, ..., n} are independently and identically distributed (i.i.d.), and
both Li and Ci are independent of Ti conditional on Zi. Define the counting pro-
cess Ni(t) = I(Li < Xi ≤ t, δi = 1) and the at-risk process Yi(t) = I(Li < t ≤ Xi).
In addition, define N(t) = n−1
∑n
i=1Ni(t), H(t) = n
−1∑n
i=1 Yi(t), and Hr(t;β) =
n−1
∑n
i=1 Yi(t)Z
⊗r
i exp(β
TZi), where r = 0, 1, 2, a
⊗0 = 1, a⊗1 = a, and a⊗2 = aaT .
The maximum partial likelihood estimator βˆ can be obtained by solving the fol-
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lowing score equations U(β) =
∑n
i=1
∫ τ
0
{Zi − Z(t;β)}dNi(t), where Z(t;β) =
H1(t;β)/H0(t;β) and τ is the end of the follow-up period such that Pr(H(τ) > 0) >
0. The cumulative baseline hazard function Λ∗0(t) =
∫ τ
0
λ∗0(s)ds can be estimated by
the Breslow estimator (Breslow, 1972), denoted as Λ̂b0(t) =
∫ t
0
dN(u)/H0(u; βˆ). These
estimators have been widely used for estimating β and Λ∗0(t) under the Cox model
for cohort studies.
2.2 Proposed Estimation Methods
For the target population P , the available information may include S(t) = Pr(T >
t), the disease-free probability at time t, and/or µ0 ≡ E{h(Z)}, where h(Z) ≡
(h1(Z), ..., hq(Z))
T is a q × 1 (known) mapping function. For example, a common
function h(·) is h(Z) = Zj, then the summary information is the mean of jth risk
factor Zj. Other functions include h(Z) = Z
2
j or ZjI(Zk = 1) if kth risk factor Zk is
binary. The expectation of these functions is the second moment of Zj or the mean
of Zj for those with Zk = 1.
Let V (t) be a generic baseline cumulative hazard function and Φ(Z;V (t),β, S(t)) =
exp{−V (t) exp(βTZ)}−S(t), for t ∈ [0, τ ]. It is easy to see that for target population
E{Φ(Z; Λ0(t),β0, S(t))} = 0, (4)
where Λ0(t) =
∫ t
0
λ0(u)du. If we assume that f(Z) is identical between P and P
∗,
we can estimate E by using the empirical risk factor distribution estimator from P ∗,
placing 1/n density mass on each of the observed data points {Zi, i = 1, ..., n}. When
S(t) at time points t = t1, ..., ts are available from P , we can re-calibrate Λ0(t) at these
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time points by solving the following estimating equation for V (t) :
n−1
n∑
i=1
Φ(Zi;V (t), βˆ, S(t)) = n
−1
n∑
i=1
[
exp{−V (t) exp(βˆTZi)} − S(t)
]
= 0. (5)
Since Φ(Z;V (t), βˆ, S(t)) is a continuous and strictly decreasing function of V (t) for
any fixed (Z, βˆ, S(t)), a unique non-negative solution to equation (5) exists when
S(t) > 0. We denote this solution as Λ̂u0(t), called an unweighted estimator. The
Newton-Raphson algorithm can be used to solve equation (5).
The proposed estimating equation E{Φ(Z; Λ0(t),β0, S(t))} = 0 has connection
with the existing methods of estimating baseline hazard by combining case-control or
cohort data with disease registry data (Pfeiffer and Gail, 2017). They proposed to es-
timate λ0(t) from external composite incidence rates through λ0(t) = {1−AR(t)}λ(t),
where AR(t) is an attributable hazard function at time t, which can be estimated from
the case-control or cohort data (Liu et al., 2014; Zhao et al., 2019), and λ(t) is the
composite incidence rate at time t for the target population. This equation is equiva-
lent to the expectation of proposed estimating equation, E{Φ(Z; Λ0(t),β0, S(t))} = 0.
This can be seen by taking the derivative of the expected estimating equation with
respect to t, yielding λ0(t) = λ(t)S(t)/E[exp(β
T
0Z) exp{−Λ0(t) exp(βT0Z)}], where
the right hand side is λ(t){1−AR(t)} under the Cox model. In fact, this equivalent
relationship between our proposed estimating equation and AR(t) holds for a general
hazard model and the proof is provided in Web Appendix E.
As noted, in practice the assumption of having a same risk factor distribution
for both the source and the target populations is stringent and implausible (Keiding
and Louis, 2016), and it is difficult to verify. If it is violated, the risk factor data
{Zi, i = 1, ..., n} from P ∗ will not represent f(Z) in the target population P , and the
equation (5) will yield biased Λ̂0(t). To reduce the bias, a natural approach is to assign
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weights to {Zi, i = 1, ..., n}, aiming at making the weighted data more representative
of the distribution of Z in P . Using the information of S(t) and µ0 = E{h(Z)} from
the target population, we can employ empirical likelihood (Owen, 1988, 2001; Qin and
Lawless, 1994) to obtain the weights, and then assign them to {Zi, i = 1, ..., n} in the
estimating equation (5). Specifically, the weights can be obtained by maximizing the
log empirical likelihood
∑n
i=1 log(wi) under the constraints of
n∑
i=1
wih(Zi) = µ0, wi > 0,
n∑
i=1
wi = 1. (6)
Standard empirical likelihood programs can be used to derive the weights (see e.g.,
http://statweb.stanford.edu/$\sim$owen/empirical/). Note that as a common
premise to use the empirical likelihood method, µ0 should fall within the convex hull
of {h(Zi), i = 1, ..., n}.
With the estimated weights, denoted by wˆi, i = 1, ..., n, now we can estimate Λ0(t)
by solving the weighted estimating equation for V (t), n−1
∑n
i=1 wˆiΦ(Zi;V (t), βˆ, S(t)) =
n−1
∑n
i=1 wˆi[exp{−V (t) exp(βˆTZi)}−S(t)] = 0. It is easy to show that a unique non-
negative solution exists for the above weighted equation when S(t) > 0. Let Λ̂w0 (t)
denote the solution to this weighted estimating equation.
Using the Lagrange multiplier, we can show that the weights satisfy wˆi = n
−1[1 +
γˆT{h(Zi) − µ0}]−1, i = 1, ..., n, where γˆ, the Lagrange multiplier for the constraint∑n
i=1wi{h(Zi) − µ0} = 0, is the solution to
∑n
i=1{h(Zi) − µ0}/[1 + γT{h(Zi) −
µ0}] = 0. This implies that the vector {Λ̂w0 (t), γˆ} can be written as the solution to
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the equations
∑n
i=1 ρ(Zi;V (t),γ,µ0, S(t), βˆ) = 0 where
ρ(Z;V (t),γ,µ, S(t),β) =
 ρ1(Z;V (t),γ,µ, S(t),β)
ρ2(Z;γ,µ)

=
 exp{−V (t) exp(βTZ)}−S(t)1+γT {h(Z)−µ}
h(Z)−µ
1+γT {h(Z)−µ}
 . (7)
The weights derived in (6) are intended to make the weighted sample representative of
the risk factor distribution of the target population. Let γ0 be the probability limits
of γˆ (The proof of its existence is provided in Web Appendix D). Essentially we have
three risk factor distributions: f ∗(Z) for P ∗ from which the individual-level data are
sampled, f(Z) for the target population P , and f †(Z) ≡ f ∗(Z)/[1 + γT0 {h(Z) −
µ0}] for an artificial population from which the weighted {Zi, i = 1, ..., n} may be
considered sampled. f †(Z) can be interpreted as the distribution closest to f ∗(Z), in
an empirical likelihood sense, but subject to the restriction that it has the expectation
of h(Z) in common with the target population.
As it will be shown in Theorem 3 in Section 3, under the general case that
E{h(Z)} 6= E∗{h(Z)}, the estimator Λ̂w0 (t) obtained from solving (8) converges
to Λ†0(t), which is the solution to E
†{Φ(Z;V (t),β0, S(t))} = 0 where E† is the
expectation taken over f †(Z). Under some conditions, the artificial distribution
f †(Z) is identical to the target distribution f(Z). When f ∗(Z) can be written as
f ∗(Z) = f(Z)[1 + γT1 {h(Z)− µ0}] for some vector γ1, then matching on the ex-
pectation E{h(Z)} will lead to an artificial distribution f †(Z) that is identical to
f(Z), because in this case the probability limit γ0 of γˆ will be equal to γ1. Generally
speaking, it is unlikely that matching on a few expectations will lead to an artificial
population with exactly the same distribution of Z as the target population. How-
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ever, as more expectations are matched, the artificial risk factor distribution will get
closer to the target distribution.
In practice, the true values of S(t) and µ0 are usually unavailable. Instead,
their estimates, denoted as Sˆ(t) and µˆ, may be available as part of summary-level
information that may be obtained from a sample based on the target population.
We can replace S(t) and µ0 by consistent estimators Sˆ(t) and µˆ, respectively, in
the estimating equations
∑n
i=1 ρ(Zi;V (t),γ,µ0, S(t), βˆ) = 0 to estimate Λ0(t). The
variance estimator of Λ̂w0 (t) thus also needs to account this additional variation in
Sˆ(t) and µˆ, which we will consider for inference in Section 3.
Note that auxiliary variables may also help refine the weights. Let W be an addi-
tional s×1 variable vector recorded in the source study and its summary information
is available from the target population. When the external information of some com-
ponents of Z is unavailable, W may be served as surrogate if it is correlated with
these components. Then the external summary information based on both Z and W
provides more auxiliary information than solely on Z, in recovering the risk factor
distribution of the target population. For example, the Charlson comorbidity index
predicts the one-year mortality for a patient who may have a range of comorbid con-
ditions, such as heart disease, AIDS, or cancer (a total of more than 20 conditions).
Each condition is assigned a score depending on the risk of dying associated with the
condition and scores are summed to provide a total score to predict overall mortality.
Assume the source cohort has the information of all the conditions and thus the score,
but the target only has summary information of partial conditions. Then these par-
tial conditions can be used as surrogates in place of the Charlson comorbidity index
for constraining purposes.
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3 LARGE SAMPLE RESULTS
In this section we establish the large sample results of the proposed estimators and
show the consistency and asymptotic normality of Λ̂u0(t) and Λ̂
w
0 (t) under regularity
conditions, which are listed in Web Appendix A. Let n be the source study sample size
from P ∗ that we have individual-level data, m be the sample size of the study from the
target population P that the summary statistics are based on, and r = limn→∞ n/m.
First, we establish the consistency and asymptotic normality of unweighted esti-
mator Λ̂u0(t) in Theorem 1.
Theorem 1. Assume the risk factor distributions are common between P and P ∗,
i.e., f(Z) = f ∗(Z). Under regularity conditions A1-A3, Λ̂u0(t) is consistent to Λ0(t),
where Λ0(t) is the true cumulative baseline hazard function in the target population,
and
√
n{Λ̂u0(t) − Λ0(t)} converges to a zero mean normal distribution with variance
σ21(t); the formula is provided in Web Appendix B.
The 1− α confidence interval of Λ0(t) can be constructed as
(Λ̂u0(t)− z1−α/2 σˆ1(t)/
√
n, Λ̂u0(t) + z1−α/2 σˆ1(t)/
√
n), (8)
where z1−α/2 is the 1− α/2 upper quantile of the standard normal distribution, and
σˆ1(t) is the estimator of σ1(t) obtained by replacing the expectations and parameters
with corresponding empirical counterparts and parameter estimates, respectively.
Next, we establish the large sample results for the weighted estimator Λ̂w0 (t) in
Theorem 2 when f(Z) = f ∗(Z).
Theorem 2. Assume f(Z) = f ∗(Z). Under regularity conditions A1-A5, we have
γ0 = 0 and Λ̂
w
0 (t) is consistent to Λ0(t). With additional condition A6,
√
n{Λ̂w0 (t)−
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Λ0(t)} converges to a zero mean normal distribution with variance σ22(t); the formula
is provided in Web Appendix C.
When n/m is low, that is, the sample size from the target population P that
generates the summary statistics is much larger than the source cohort from P ∗, we
show that σ22(t) < σ
2
1(t), indicating that weighted estimator is asymptotically more
efficient than the unweighted estimator. The proof is provided in Web Appendix C.
Intuitively, the additional information imposes constraints on the full parameter space
to a reduced parameter space, and if this additional information is precise, it will gain
efficiency and the extent will depend on how precise this additional information is.
In the preceding theorems we assume that the two populations have a common
distribution of Z. This needs not be the case. The proposed weighted estimator is
motivated by the presumption that the two populations have different distributions of
Z and thus probably different expectations of h(Z). The large sample results under
this situation are given in the following theorem.
Theorem 3. Under regularity conditions A1-A5, Λ̂w0 (t) is consistent to Λ
†
0(t), where
Λ†0(t) is the solution to E
†{Φ(Z;V (t),β0, S(t))} = 0 where E† is the expectation
taken over f †(Z). With additional condition A6,
√
n{Λ̂w0 (t) − Λ†0(t)} converges to a
zero mean normal distribution with variance σ23(t); the formula is provided in Web
Appendix D.
Based on the asymptotic normality in Theorem 3, the 1 − α confidence interval
of Λ†0(t) can be constructed as
(Λ̂w0 (t)− z1−α/2 σˆ3(t)/
√
n, Λ̂w0 (t) + z1−α/2 σˆ3(t)/
√
n), (9)
where z1−α/2 is the 1− α/2 upper quantile of the standard normal distribution, and
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σˆ3(t) is obtained by replacing the expectations with empirical counterparts and pa-
rameters with their estimates. This confidence interval can serve as an approximation
to the (1− α) confidence interval for Λ0(t).
Let Σµ be the limiting variance covariance matrix of
√
mµˆ and Σµ,S(t) the limiting
covariance vector of
√
mµˆ and
√
mSˆ(t). Variance σ23(t) includes Σµ and Σµ,S(t) as
components. In practice, however, their estimates are often unavailable except for
the diagonal elements of Σµ (i.e., the variance components). One alternative is to let
all off-diagonal elements of Σµ and all elements of Σµ,S(t) be 0. By this the resulting
estimator, denoted as σˆd3 , would approximate σˆ3 well, if either one of the following
two conditions holds: (1) the off-diagonal elements of Σµ and all elements of Σµ,S(t)
are close to zero; and (2) the ratio of sample sizes, n/m, is low.
When the distribution of Z between the two populations differ, the estimator
Λ̂w0 (t) using summary information of risk factors has the potential to reduce bias
compared to unweighted Λ̂u0(t) which does not utilize the risk factor summary infor-
mation, and the confidence interval (9) has thus better coverage probability of Λ0(t)
than (8). Therefore, under the common situation that individual-level data from the
target population are not available, the estimator Λ̂w0 (t) with the confidence inter-
val (9) would be a more robust solution to external calibration of baseline hazard
function.
Sometimes investigators are interested in risk predictions at several different time
points, ranging from short term to long term projection. The asymptotic derivations
for a single value of t can be straightforwardly extended to allow for multiple values
of t based on the proof in Web Appendix D. In addition, the proposed inference
procedure can be easily modified to accommodate the scenario where the summary
information (Sˆ(t), µˆ) are obtained from multiple sources..
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4 ABSOLUTE RISK ESTIMATION
Once we obtain Λ̂0(t) and β̂, we can calculate the risk for developing disease for an
individual given his/her risk profile. Sometimes the competing risks need to be taken
into account. In our real data analysis example of colorectal cancer, as the cancer
tends to occur in older ages, individuals may die of other causes before developing
colorectal cancer. As such, it is important to account for death when calculating
the risk for developing colorectal cancer. For a person who is free of both events of
interest and competing risks at age t0 with a risk profile of Z, the absolute risk of
experiencing the event of interest before age t1 in the presence of competing event is
defined as (Pfeiffer and Gail, 2017)
Pr(t0 < T ≤ t1,∆ = 1|T > t0,Z) =
∫ t1
t0
λ(u|Z) exp[−
∫ u
t0
{λ(s|Z) + λc(s|Z)}ds]du,
where T is the time to the first event, ∆ is the event type with values of 1 and 2
indicating the event of interest and competing event, respectively, λ(t|Z) and λc(t|Z)
are the respective cause-specific hazard functions at age t given Z, respectively.
We can use the same method in Section 2 for estimating the baseline hazard
function for the event of interest in the presence of competing risks. In equation
(4), the summary statistic S(t) from the target population may be replaced by the
commonly used Kaplan-Meier estimator or exponent of the negative NelsonAalen
estimator, obtained by treating individuals who experience competing events first
as censored at that time. The theoretical results in Section 3, which assumes the
covariates Z having no effects on the time to competing risk, provide an approximated
solution to calculating the variance of the baseline hazard function estimator in the
presence of competing risk. Subsequently, one can obtain the variance of the absolute
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risk estimator by the delta method (see Web Appendix D).
5 SIMULATION STUDIES
We conducted extensive simulation to evaluate the finite sample performance of the
proposed method under various scenarios. Specifically, we assumed that the effects of
risk factors on the hazard function in both the source and target populations followed
the Cox proportional hazards models (2) and (3), respectively. We considered a
Weibull distribution for the baseline hazard function Λ0(t) = (θt)
ν . For the target
population P , we assumed θ = 0.01 and ν = 2; for the source population P ∗, we
considered four parameter combinations: (A1) θ = 0.01, ν = 2; (A2) θ = 0.01,
ν = 1.5; (A3) θ = 0.008, ν = 2; (A4) θ = 0.008, ν = 1.5. Under A1, Λ0(t) is the same
for both P and P ∗, and differs with varying degree under other scenarios.
We generated two exposure variablesZ = (Z1, Z2)
T . For P ∗, Z1 ∼ Bernoulli(0.5),
Z2 ∼ N(0, 1) and Z1 ⊥ Z2; for P , we considered the following four configurations:
(C1) f(Z) = f ∗(Z); (C2) Z1 ⊥ Z2, f(Z2) is same, but Z1 ∼ Bernoulli(0.8); (C3)
f(Z1) is same but Z2|Z1=1 ∼ N(0.5, 1.2) and Z2|Z1=0 ∼ N(−0.5, 0.8); and (C4)
Z1 ∼ Bernoulli(0.8), Z2|Z1=1 ∼ N(0.5, 1.2) and Z2|Z1=0 ∼ N(−0.5, 0.8). We set the
corresponding coefficients β0 = {log(2), log(2)}. We generated right censoring time
C = C∗I(1 ≤ C∗ ≤ 100) + I(C∗ < 1) + 100I(C∗ > 100), where C∗ ∼ N(40 + ζZ1, 15),
ζ = −5, 0, 5. This yields approximately 64% to 85% censoring rates under various
scenarios, representing moderate to high levels of censoring. The observed failure
time was rounded to the nearest integer to mimic the real-world data. The sample
size of the source study was n = 1, 000, representing moderate source cohort size. To
generate the summary information from the target population, we generated a cohort
from the target population and obtained the Kaplan-Meier estimator of disease-free
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probabilities and first- and second-moments of (Z1, Z2). Note that the Kaplan-Meier
estimator is not consistent given that censoring time is only conditionally independent
of failure time given Z1; however, this is a commonly available statistic for disease-
free probabilities in practice and hence we used it here. For the sample size of the
target cohort, we considered m = 200, 1, 000 and 100, 000, representing small, moder-
ate and large sample sizes of the external information resources. We generated 2,000
replicates for each simulation setting.
We compared six methods: the Breslow estimator Λ̂B0 (t) based on the source
cohort data, the unweighted estimator Λ̂u0(t), weighted estimators Λ̂
w
0 (t) with four
different constraints on Z each having more constraints than the previous one: E(Z1),
{E(Z1),E(Z2)}, {E(Z1),E(Z2),E(Z22)}, and {E(Z1),E(Z2I(Z1 = 1)),E(Z22I(Z1 = 1)),
E(Z2I(Z1 = 0)),E(Z
2
2I(Z1 = 0))}. We denoted the four weighted estimators as Λ̂w0,1(t),
Λ̂w0,2(t), Λ̂
w
0,3(t) and Λ̂
w
0,4(t), respectively. The Breslow estimator Λ̂
B
0 (t) is served as a
basic model for comparing the performance with other methods, since it represents a
conventional solution when no auxiliary external information is used.
We assessed the performance of these estimators by the following metrics: percent-
age of relative bias (PBias), empirical standard deviation (ESD), asymptotic-based
standard error (ASE), square root of mean squared error (sMSE), and coverage prob-
ability of 95% confidence intervals over the true value of Λ0(t) (CP) at selected ages
t = 20, 40, and 60. We also calculated the average cumulative absolute deviation
(CAD),
∑Tmax
t=1 |Λ̂0(t) − Λ0(t)|, where Tmax = 60 and Λ̂0(t) is an estimator of Λ0(t)
from each of the methods, to assess the overall performance across a wide range of
time. For the variance estimator of the four weighted estimators, we set all elements
of the covariance vector Σµ,S(t) and the off-diagonal elements of Σµ to 0 since such
information is usually not available in practice.
The results are very similar for different values of ζ in the censoring distribution.
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To save space here we only present results when ζ = −5. Table 1 summarizes the
results under A1, i.e., Λ∗0(t) = Λ0(t). The target cohort sample size is m = 100, 000
which yields highly accurate external summary information. Under this scenario, the
Breslow estimator Λ̂B0 (t) obtained from the source cohort is a consistent estimator to
Λ0(t) for the target cohort. Indeed, there is little bias for Λ̂
B
0 (t) whether or not the
risk factor distribution is same between the source and target cohorts (C1–C4). On
the other hand, the unweighted estimator Λ̂u0(t) that assumes f(Z1, Z2) = f
∗(Z1, Z2)
is unbiased under C1, i.e., f ∗(Z1, Z2) = f(Z1, Z2), but can be substantially biased
when f ∗(Z1, Z2) 6= f(Z1, Z2) under C2–C4 with relative bias as high as 73%, even
though Λ∗0(t) = Λ0(t). The weighted estimator, especially Λ̂
w
0,4(t), has little bias
with maximum relative bias 3% and the CAD and sMSE are often the lowest. The
coverage probability of 95% confidence intervals is close to 95%. As expected, as more
constraints are added, the bias of the weighted estimator becomes smaller.
When f ∗(Z1, Z2) = f(Z1, Z2), the weighted estimators and also the unweighted es-
timator that leverage the (precise) summary information from target cohort improve
the efficiency substantially with efficiency gain over 200%. Even when f(Z1, Z2) is
significantly different from f ∗(Z1, Z2) under C4, the weighted estimators does not
lose much efficiency compared to the Breslow estimator. The asymptotic-based vari-
ance estimator is close to empirical variance estimator, suggesting that setting the
covariance Σµ,S(t) and the off-diagonal elements of Σµ to 0 does not bias the vari-
ance estimator in any meaningful fashion. In some situations where the off-diagonal
elements of Σµ is available, we can incorporate such information in the variance es-
timator; however, the variance estimator is almost identical to the one that sets the
off-diagonal elements to 0 (Supplemental Table S1).
Table 2 shows the results when Λ0(t) 6= Λ∗0(t) under A2 where they differ by the
shape parameter. The conventional Breslow estimator Λ̂B0 (t) has poor performance
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Table 1: Summary statistics of simulation results for scenario A1: Λ∗0(t) = Λ0(t) =
(0.01t)2, n = 1, 000, and m = 100, 000.
(C1) Z1 ∼ Bernoulli(0.5), Z2 ∼ N(0, 1), (C2) Z1 ∼ Bernoulli(0.8), Z2 ∼ N(0, 1),
and Z1 ⊥ Z2, i.e., f∗(Z1, Z2) = f(Z1, Z2) and Z1 ⊥ Z2
t Λ0(t) Λ̂B0 (t) Λ̂
u
0(t) Λ̂
w
0,1(t) Λ̂
w
0,2(t) Λ̂
w
0,3(t) Λ̂
w
0,4(t) Λ̂
B
0 (t) Λ̂
u
0(t) Λ̂
w
0,1(t) Λ̂
w
0,2(t) Λ̂
w
0,3(t) Λ̂
w
0,4(t)
20 0.04 PBias 0.4% 1.1% 1.1% 1.1% 1.1% 1.0% 0.2% 21.7% 2.5% 1.8% 1.8% 1.8%
ESD 0.65 0.44 0.44 0.43 0.42 0.42 0.65 0.52 0.58 0.54 0.54 0.54
ASE 0.65 0.47 0.46 0.43 0.42 0.42 0.65 0.57 0.59 0.55 0.54 0.54
sMSE 0.65 0.44 0.44 0.43 0.43 0.43 0.65 1.05 0.58 0.55 0.54 0.55
CP 94.3% 96.3% 95.9% 95.6% 95.1% 94.6% 94.6% 67.4% 95.9% 96.1% 95.7% 95.6%
40 0.16 PBias -0.8% 1.0% 1.0% 1.0% 1.0% 1.0% -1.0% 22.8% 2.4% 1.7% 1.7% 1.7%
ESD 1.89 1.53 1.52 1.47 1.47 1.47 1.90 1.77 2.12 1.98 1.97 1.98
ASE 1.87 1.64 1.56 1.47 1.45 1.43 1.87 1.94 2.12 2.00 1.98 1.98
sMSE 1.90 1.54 1.53 1.48 1.48 1.47 1.90 4.14 2.16 1.99 1.99 2.00
CP 93.7% 96.2% 95.8% 95.3% 95.0% 94.6% 93.1% 52.1% 95.2% 95.7% 95.7% 95.5%
60 0.37 PBias -3.2% 1.0% 0.9% 0.9% 0.9% 0.9% -3.0% 24.0% 2.3% 1.6% 1.6% 1.7%
ESD 4.34 2.98 2.95 2.83 2.83 2.83 4.33 3.44 4.47 4.12 4.12 4.14
ASE 4.22 3.16 2.97 2.80 2.79 2.77 4.24 3.71 4.38 4.16 4.15 4.14
sMSE 4.49 3.00 2.97 2.85 2.85 2.85 4.47 9.43 4.55 4.16 4.16 4.19
CP 91.8% 95.8% 95.1% 95.1% 95.2% 94.9% 91.3% 31.8% 93.7% 95.7% 95.6% 95.5%
CAD 0.73 0.54 0.54 0.52 0.52 0.52 0.74 1.76 0.77 0.71 0.71 0.72
(C3) Z1 ∼ Bernoulli(0.5), (C4) Z1 ∼ Bernoulli(0.8),
Z2|Z1=1 ∼ N(0.5, 1.2), Z2|Z1=1 ∼ N(0.5, 1.2),
and Z2|Z1=0 ∼ N(−0.5, 0.8) and Z2|Z1=0 ∼ N(−0.5, 0.8)
t Λ0(t) Λ̂B0 (t) Λ̂
u
0(t) Λ̂
w
0,1(t) Λ̂
w
0,2(t) Λ̂
w
0,3(t) Λ̂
w
0,4(t) Λ̂
B
0 (t) Λ̂
u
0(t) Λ̂
w
0,1(t) Λ̂
w
0,2(t) Λ̂
w
0,3(t) Λ̂
w
0,4(t)
20 0.04 PBias -0.3% 22.0% 22.0% 21.9% 15.1% 0.4% 0.3% 73.0% 45.5% 12.3% 4.7% 1.3%
ESD 0.65 0.52 0.51 0.50 0.50 0.55 0.64 0.72 0.82 0.67 0.65 0.66
ASE 0.64 0.57 0.55 0.51 0.50 0.54 0.65 0.79 0.82 0.65 0.64 0.65
sMSE 0.65 1.06 1.06 1.05 0.81 0.55 0.64 3.15 2.08 0.85 0.68 0.66
CP 93.8% 65.6% 63.0% 58.7% 77.8% 94.2% 94.8% 0.6% 35.1% 91.6% 95.2% 94.5%
40 0.16 PBias -1.3% 12.0% 12.0% 12.0% 8.1% 1.4% -1.5% 63.4% 36.0% 7.6% 5.2% 2.4%
ESD 1.89 1.65 1.64 1.60 1.57 1.69 1.87 2.26 2.79 2.21 2.16 2.21
ASE 1.87 1.79 1.71 1.60 1.57 1.67 1.86 2.46 2.75 2.20 2.17 2.21
sMSE 1.90 2.57 2.56 2.53 2.05 1.70 1.89 10.65 6.53 2.53 2.32 2.25
CP 94.1% 84.3% 81.9% 78.8% 88.9% 95.0% 94.0% 0.2% 44.6% 94.4% 95.2% 95.8%
60 0.37 PBias -2.9% 2.9% 2.8% 2.8% 1.3% 1.8% -3.3% 53.7% 26.6% 2.3% 3.9% 3.0%
ESD 4.30 3.01 2.98 2.87 2.84 2.96 4.21 4.06 5.49 4.22 4.18 4.29
ASE 4.24 3.21 3.01 2.84 2.81 2.91 4.24 4.36 5.27 4.26 4.26 4.34
sMSE 4.43 3.19 3.15 3.05 2.88 3.04 4.38 20.06 11.17 4.30 4.42 4.43
CP 91.3% 95.6% 94.8% 94.3% 95.2% 95.1% 92.2% 0.1% 59.6% 96.2% 95.8% 96.3%
CAD 0.74 0.88 0.87 0.86 0.70 0.60 0.72 4.60 2.54 0.87 0.81 0.80
NOTE: PBias, the relative bias; ESD, the empirical standard deviation (×100) of the 2000 estimates; ASE, the
mean of the asymptotic-based standard error (×100); sMSE, the square root of mean squared error (×100); CP,
the coverage probability of a 95% confidence interval for Λ0(t); CAD, the average cumulative absolute deviation
between the estimated and true cumulative hazard function across a time range of one through sixty.
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Table 2: Summary statistics of simulation results for scenario A2: Λ0(t) = (0.01t)
2,
Λ∗0(t) = (0.01t)
1.5, n = 1, 000, and m = 100, 000.
(C1) Z1 ∼ Bernoulli(0.5), Z2 ∼ N(0, 1), (C2) Z1 ∼ Bernoulli(0.8), Z2 ∼ N(0, 1),
and Z1 ⊥ Z2, i.e., f∗(Z1, Z2) = f(Z1, Z2) and Z1 ⊥ Z2
t Λ0(t) Λ̂B0 (t) Λ̂
u
0(t) Λ̂
w
0,1(t) Λ̂
w
0,2(t) Λ̂
w
0,3(t) Λ̂
w
0,4(t) Λ̂
B
0 (t) Λ̂
u
0(t) Λ̂
w
0,1(t) Λ̂
w
0,2(t) Λ̂
w
0,3(t) Λ̂
w
0,4(t)
20 0.04 PBias 120.3% 1.1% 1.0% 1.0% 1.0% 1.0% 120.4% 21.7% 2.3% 1.5% 1.5% 1.6%
ESD 1.10 0.37 0.37 0.36 0.36 0.35 1.08 0.44 0.49 0.46 0.46 0.46
ASE 1.08 0.43 0.41 0.38 0.37 0.36 1.08 0.51 0.52 0.47 0.47 0.46
sMSE 5.18 0.37 0.37 0.36 0.36 0.36 5.17 1.01 0.50 0.47 0.46 0.47
CP 0.1% 97.7% 97.1% 96.1% 96.1% 95.5% 0.0% 59.6% 95.5% 95.5% 95.0% 94.9%
40 0.16 PBias 55.2% 1.0% 0.9% 0.9% 0.9% 0.9% 55.4% 22.8% 2.3% 1.4% 1.4% 1.5%
ESD 2.52 1.27 1.26 1.22 1.21 1.21 2.42 1.53 1.83 1.69 1.68 1.69
ASE 2.44 1.47 1.38 1.27 1.26 1.24 2.45 1.73 1.86 1.72 1.71 1.70
sMSE 9.39 1.28 1.27 1.23 1.22 1.22 9.40 4.03 1.87 1.70 1.70 1.70
CP 1.8% 97.9% 96.9% 95.7% 95.5% 95.0% 1.6% 41.6% 94.6% 95.3% 95.1% 95.1%
60 0.37 PBias 25.2% 0.8% 0.8% 0.8% 0.8% 0.8% 25.2% 23.9% 2.2% 1.3% 1.3% 1.4%
ESD 4.83 2.49 2.47 2.34 2.34 2.34 4.82 2.99 3.91 3.54 3.54 3.55
ASE 4.78 2.83 2.61 2.41 2.41 2.39 4.77 3.31 3.82 3.56 3.56 3.55
sMSE 10.41 2.51 2.48 2.36 2.36 2.36 10.39 9.25 3.99 3.57 3.57 3.58
CP 53.7% 97.5% 96.3% 95.2% 95.4% 95.1% 52.9% 20.3% 93.1% 95.4% 95.4% 95.3%
CAD 3.89 0.46 0.45 0.44 0.43 0.43 3.89 1.75 0.67 0.61 0.61 0.61
(C3) Z1 ∼ Bernoulli(0.5), (C4) Z1 ∼ Bernoulli(0.8),
Z2|Z1=1 ∼ N(0.5, 1.2), Z2|Z1=1 ∼ N(0.5, 1.2),
and Z2|Z1=0 ∼ N(−0.5, 0.8) and Z2|Z1=0 ∼ N(−0.5, 0.8)
t Λ0(t) Λ̂B0 (t) Λ̂
u
0(t) Λ̂
w
0,1(t) Λ̂
w
0,2(t) Λ̂
w
0,3(t) Λ̂
w
0,4(t) Λ̂
B
0 (t) Λ̂
u
0(t) Λ̂
w
0,1(t) Λ̂
w
0,2(t) Λ̂
w
0,3(t) Λ̂
w
0,4(t)
20 0.04 PBias 119.7% 21.8% 21.8% 21.7% 14.9% 0.1% 119.9% 72.9% 45.2% 11.9% 4.4% 0.9%
ESD 1.07 0.44 0.44 0.42 0.42 0.46 1.09 0.64 0.73 0.58 0.56 0.57
ASE 1.08 0.51 0.48 0.45 0.44 0.47 1.08 0.71 0.72 0.56 0.55 0.56
sMSE 5.14 1.02 1.02 1.01 0.76 0.46 5.16 3.13 2.03 0.77 0.59 0.57
CP 0.0% 59.4% 53.8% 46.9% 73.0% 94.8% 0.0% 0.0% 22.1% 88.3% 94.6% 94.7%
40 0.16 PBias 54.9% 11.8% 11.8% 11.8% 7.9% 1.1% 54.8% 63.4% 35.8% 7.3% 5.0% 2.2%
ESD 2.49 1.41 1.40 1.33 1.31 1.42 2.49 2.03 2.50 1.92 1.88 1.93
ASE 2.45 1.61 1.51 1.39 1.36 1.44 2.44 2.20 2.41 1.89 1.87 1.90
sMSE 9.35 2.40 2.40 2.35 1.84 1.43 9.32 10.59 6.38 2.27 2.06 1.96
CP 2.4% 82.6% 79.9% 75.9% 86.4% 95.7% 2.2% 0.0% 32.5% 92.9% 95.0% 95.0%
60 0.37 PBias 25.0% 2.7% 2.7% 2.7% 1.2% 1.6% 24.9% 53.7% 26.5% 2.1% 3.8% 2.9%
ESD 4.87 2.56 2.53 2.37 2.35 2.43 4.81 3.70 4.99 3.72 3.70 3.80
ASE 4.78 2.87 2.65 2.45 2.43 2.50 4.77 3.89 4.60 3.67 3.67 3.73
sMSE 10.37 2.74 2.72 2.56 2.39 2.51 10.30 19.99 10.89 3.80 3.95 3.95
CP 54.3% 96.3% 95.2% 94.5% 95.9% 95.2% 54.8% 0.0% 48.0% 95.3% 95.0% 95.3%
CAD 3.87 0.82 0.82 0.80 0.62 0.49 3.86 4.60 2.52 0.77 0.72 0.70
NOTE: PBias, the relative bias; ESD, the empirical standard deviation (×100) of the 2000 estimates; ASE, the
mean of the asymptotic-based standard error (×100); sMSE, the square root of mean squared error (×100); CP,
the coverage probability of a 95% confidence interval for Λ0(t); CAD, the average cumulative absolute deviation
between the estimated and true cumulative hazard function across a time range of one through sixty.
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with relative bias ranging from 24.9% to 120.4%. The unweighted estimator has little
bias when the assumption of f(Z1, Z2) = f
∗(Z1, Z2) holds, but can be substantially
biased when it is violated. By further constraining on the moments of risk factors,
the weighted estimators reduce the bias, and with adequate constraints, the weighted
estimator, e.g., Λ̂w0,4(t), is nearly unbiased. The asymptotic-based variance estima-
tor is close to empirical variance estimator and the coverage probability is close to
95% nominal level. Under C1 f(Z1, Z2) = f
∗(Z1, Z2) when both unweighted and
weighted estimators are unbiased, including additional constraints on the moments
of risk factors improves efficiency slightly.
We examined the performance of all the estimators when Λ0(t) differs from the
source cohort Λ∗0(t) by the scale parameter (A3) and by both the shape and scale
parameters (A4). The results have similar patterns to that under A2 (Supplemental
Table S2 and S3). We also examined the performance when the sample sizes for
obtaining auxiliary information from the target cohort are moderate (m = 1, 000,
Supplemental Table S4-S7) and low (m = 200, Supplemental Table S8-S11). Under
Λ0(t) = Λ
∗
0(t) when all estimators are almost unbiased, the unweighted and weighted
estimators have comparable efficiency to the Breslow estimator when m = 1, 000, and
are less efficient when m = 200. However, even when m = 200, if the baseline hazard
functions and risk factor distributions differ between the source and target cohorts,
the auxiliary information can help reduce the bias substantially with the weighted
estimators (Table S9-S11).
We evaluated the performance of the proposed method when the competing risks
are present. If the risk score associated with the event of interest is also associated
with the competing event, the proposed estimator is no longer unbiased. Thus, we
studied the magnitude of the bias of the proposed estimator by varying the values
of the following parameters: (1) correlation of the risk score with the competing
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Figure 1: Maximal relative bias of the proposed weighted estimator Λ̂w0,4(t). Corr:
Pearson correlation coefficient between risk score for event of interest and Tc, i.e.,
corr(βT0Z, Tc). Horizontal axis: probability of observing the event of interest; ver-
tical axis: ratio between probability of observing the event of competing risk and
probability of observing the event of interest.
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event; (2) probability of observing the event of interest; and (3) ratio of the prob-
abilities of observing the competing risk and the event of interest. Specifically, we
generated covariates and time-to-event of interest under the same settings as in the
previous simulation. For simplicity, we generated the censoring time C∗ ∼ N(40, 15).
We specified Λ0(t) = κ(θt)
ν , κ = 1/16, 1/8, 1/4, 1/2, 1, 2, 4, 8, 16 to yield various
disease prevalences for the event of interest. Let Tc denote time to a compet-
ing event. We let Tc follow the Cox model with the hazard function Λc(t|Z) =
Λ0c(t) exp(β
T
cZ), where Λ0c(t) = κ(θt)
ν , with κ = 1/16, 1/8, 1/4, 1/2, 1, 2, 4, 8, 16, and
βc = (0, 0), (log(1.15), log(1.15)), (log(1.41), log(1.41)) or (log(2), log(2)), represent-
ing different strengths of association between the risk score (for the event of interest)
and Tc, and yielding Pearson correlation coefficients between the two at 0, 0.15, 0.4,
and 0.6, respectively. The results were summarized in the four contour plots in Figure
1. The contour value is the maximal relative bias maxt=20,40,60 |{Λ̂w0,4(t)−Λ0(t)}/Λ0(t)|
where Λ̂w0,4(t) is the empirical mean of Λ̂
w
0,4(t) over the 2,000 simulation. When the
correlation between Tc and risk score for the event of interest is weak (< 0.2), the
proposed weighted estimator is almost unbiased across all scenarios. Note that the
correlation coefficients are around −0.1 in our real-data examples. When the cor-
relation is moderate (∼ −0.4), the maximal relative bias is below 10% when the
censoring proportion is moderate to high (> 50%). When the correlation is high
(∼ −0.6), the maximal relative bias is still below 10% when the censoring propor-
tion is high (> 70%) and the ratio between probabilities of observing the competing
event versus observing the event of interest is not high (< 3). In addition, we found
the coverage probability of 95% confidence interval using the variance estimator from
Theorem 3 is generally above 90% when the absolute bias is below 5% (Supplemental
Figure S1), reflecting good performance of the inference.
In summary, the proposed weighted estimator incorporating disease incidence and
25
auxiliary risk factor information from target cohort reduces bias substantially com-
pared to the conventional Breslow estimator and the unweighted estimator, both of
which can lead to unacceptable large bias, when the baseline hazard function and/or
risk factor distribution differ between the two cohorts. The weighted estimator can
also gain substantial efficiency when f ∗(Z1, Z2) = f(Z1, Z2) and the auxiliary external
risk factor information is of high accuracy and precision. The proposed estimator is
also quite robust across a wide range of realistic scenarios under the competing risks.
6 APPLICATION
6.1 Study Cohorts and Risk Factors
In this section we illustrate an application of our methodology by re-calibrating a
colorectal cancer (CRC) risk prediction model, established from the Women’s Health
Initiative (WHI), to five target cohorts: the intervention and control arms of the
Prostate, Lung, Colorectal and Ovarian Cancer Screening Trail (PLCO) study and
three countries (England, Scotland, and Wales) from the UK Biobank (UKB). In
particular, we will use the WHI individual-level data to build the risk prediction
model, and leverage the summary statistics from the target cohorts, which include
overall hazard rates of CRC and means of key risk factors, to re-calibrate the CRC
baseline hazard function for the target cohorts. We accommodated the death from
other causes as the competing event in the calculation of absolute risk. Below we
describe the three studies.
The WHI observational cohort is a prospective study including 93,676 women
aged 50 to 79 years in the U.S. between 1993 and 1998 (Womens Health Initiative
Study Group, 1998). The study collects information on socio-demographic and epi-
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demiologic factors using standardized questionnaires, and biological samples at clinic
visits. Here we focus on disease risk of CRC for white women. A total of 76,733
subjects are included in the estimation of disease risk, with mean follow-up length of
6.7 years. Among these, 1,073 developed CRC and 8,815 died from causes other than
CRC during the follow-up. The disease outcome is age (in integer years) at diagnosis
of CRC, which is subject to left truncation (age at enrollment), right censoring (age
at the end of follow-up, loss of follow-up, or death from other causes).
The PLCO study is a large randomized trial conducted to determine the effective-
ness of screening in reducing cancer mortality (Prorok et al., 2000; Gohagan et al.,
2000). It enrolled 154,934 participants aged between 55 and 74 years at 10 cen-
ters from 1993 to 2001. To be consistent with WHI, we included only white women
(67,254 participants) from PLCO. The mean follow-up length is 11.3 years. During
the follow-up 749 women developed CRC and 6,241 died from other causes. As PLCO
is a screening trial, we used the intervention and control arms separately as two target
cohorts. Note that PLCO and WHI are both conducted within the U.S. nationally.
To further illustrate recalibration targeted to populations that are more different from
the source cohort, we used cohorts assembled from the UK Biobank (UKB) as target
cohorts. UKB is a large long-term biobank study in the United Kingdom, aimed
to improve the prevention, diagnosis and treatment of a wide range of serious and
life-threatening illnesses including cancer, heart diseases, and diabetes (Sudlow et al.,
2015). It recruited 500,000 people aged between 40-69 years in 2006-2010 from across
UK except for Northen Ireland and is following the health and well-being of these
participants. To be consistent with WHI, only white women (198,058 participants)
with enrollment age greater than 50 from UKB were included. The mean follow-up
length is 5.8 years; 1,150 developed CRC and 4,623 died from other causes during
the follow-up. We analyzed the three countries, England, Scotland and Wales, sepa-
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rately. In total, we have two PLCO-based target cohorts and three UKB-based target
cohorts.
The risk factors included in the risk prediction model are based on the model
developed by Freedman et al. (2009). These are history of endoscopy (sigmoidoscopy
or colonoscopy) in last five years (yes, no); number of first-degree relatives with CRC
(0, ≥ 1); current leisure-time vigorous activity (0, 0-2, > 2 hours per week); use of
aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) (nonuser, regular
user); vegetable consumption (< , ≥ medium portion per day); body mass index
(BMI, < 30, ≥ 30kg/m2); and estrogen status within the last two years (negative,
positive). We fit a Cox proportional hazards model, treating the competing risk of
other-cause mortaility as censored. Since no women below age 50 were recruited in
WHI, we built the model only starting at age 50. For women who enrolled after age
50, they were treated as left truncated at the enrollment age. For example, a woman
enrolled at age 60 and developed CRC at age 70 would only be in the at-risk set
for developing disease between age 60 and 70. This problem can be appropriately
handled by carefully defining the at-risk set for each subject as described in Section
2.1.
We compared summary information including Kaplan-Meier estimator of CRC-
free probability and risk factor distributions across cohorts to determine the need for
recalibration. We then applied the proposed methods using the summary information
from target cohorts to recalibrate the CRC cumulative baseline hazard function and
calculated the t-year absolute risks for individuals in the target cohorts.
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Figure 2: Probabilities of developing colorectal cancer for the WHI and five target
cohorts obtained by 1 - Kaplan-Meier estimator.
6.2 Results
Figure 2 shows the probability of developing colorectal cancer from 50 to 80 years
old for the WHI and five target cohorts. It is obvious that these cohorts have very
different disease probabilities, justifying the need to leverage CRC risk estimates from
the target cohorts for re-calibration.
Table 3 presents the descriptive statistics and hazard ratio estimates from the
Cox model. We assessed the proportional hazards assumption for all the risk factors
(Grambsch and Therneau, 1994) and the p-values are all greater than 0.05, suggest-
ing there is no evidence the proportionality assumption underlying the Cox model
is violated. Generally, having a positive family history in the first-degree relatives
and being obese increase CRC risk, while having had endoscopy, more exercise, As-
pirin/NSAIDS use, greater vegetable intake and positive estrogen status reduce risk.
The prevalences of risk factors are very similar between WHI and the two arms
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Table 3: Prevalence of risk factors and outcome statistics for WHI, PLCO and UKB.
Hazard ratio estimates (95% confidence interval [CI]) for CRC are based on the WHI
data.
Prevalence
PLCO PLCO UKB UKB UKB WHI
Risk Factor/Outcome WHI ctrl intv England Scotland Wales HR (95% CI)
No. of subjects 76,733 33,510 33,744 175,248 14,740 8,070
Endoscopy history 56.2% 10.1% 73.9% 37.7% 24.7% 23.7% 0.79 (0.70, 0.89)
No. of relatives with CRC (≥1) 14.7% 11.1% 11.5% 11.9% 12.4% 10.7% 1.24 (1.06, 1.45)
Vigorous leisure exercise 0-2 hr/wk 14.9% 23.3% 23.1% 33.9% 33.6% 30.9% 0.99 (0.83, 1.18)
Vigorous leisure exercise >2 hr/wk 12.1% 11.6% 11.6% 14.5% 13.6% 13.0% 0.83 (0.68, 1.03)
Aspirin/NSAID use (Regular user) 85.0% 47.6% 48.0% 24.6% 26.0% 24.9% 0.76 (0.65, 0.90)
Vegetable intake (≥median portion/day) 53.0% 50.2% 50.7% 46.4% 45.3% 44.6% 0.94 (0.83, 1.06)
BMI, kg/m2 (≥30) 22.8% 23.6% 24.1% 24.1% 24.2% 28.4% 1.39 (1.21, 1.59)
Estrogen status (Positive) 44.9% 50.6% 50.7% 8.3% 6.8% 7.6% 0.87 (0.76, 0.99)
Mean follow-up years 6.7 11.3 11.2 5.7 6.9 6.7
Other-cause mortality rate (5-year) 3.8% 2.0% 2.1% 1.4% 1.6% 1.4%
CRC rate (5-year) 0.7% 0.5% 0.3% 0.5% 0.5% 0.4%
No. of risk factors for constraints 2 2 4 4 4
NOTE: PLCO ctrl, PLCO control arm; PLCO intv, PLCO intervention arm. Gray context indicates the prevalence
difference compared to WHI is greater than 10%.
of PLCO, except for endoscopy history (WHI 56.2%, PLCO intervention arm 73.9%,
PLCO control arm 10.1%)and Aspirin/NSAID use (WHI 85.0%, PLCO ∼48%). For
the three target cohorts from UKB, notably fewer participants have had endoscopy,
use NSAIDS and have positive estrogen status but more participants have moderate
exercise (0-2 hours/week) than WHI participants. Such discrepancy justifies the need
to re-weight the risk factor distribution for the target PLCO and UKB cohorts.
A key aspect of risk model validation is that the model can predict the risk for
developing disease accurately. To investigate the calibration performance of the pro-
posed methods, for each participant in the targeted cohort, we calculated 5-year
absolute risk of developing CRC from the enrollment age based on the risk prediction
model, accounting for the competing risks of death from other causes for which the
cause-specific hazard functions were estimated from the target cohorts. We strati-
fied participants into five evenly distributed groups according to the levels of their
30
model-based absolute risk estimates. Then for each risk group, we calculated the
empirical absolute risk of 5-year CRC risk accounting for competing risks based on
the non-parametric estimator (Gray et al., 1988). We expect that a well calibrated
model would yield absolute risk estimates, which match well to empirical absolute
risks across all levels of risk groups.
Figure 3 shows the comparison of average model-based and empirical absolute risk
estimates in each risk group, for three models: the WHI model and the re-calibrated
models with unweighted Λ̂u0(t) and weighted Λ̂
w
0 (t) (constraints for selected risk fac-
tors for each target cohort are highlighted in gray in Table 3). The WHI model used
the competing hazard function estimated from the WHI data and the recalibrated
models used the competing hazards based on the target cohort data. The absolute
risk estimation of the original WHI model is not well calibrated to both PLCO target
cohorts. The average model-based absolute risk estimates are far above the upper
bounds of the 95% confidence intervals (CI) of the empirical absolute risk estimates.
The re-calibrated unweighted estimator improves the calibration substantially. The
95% CIs of empirical absolute risk estimates generally cover the model-based esti-
mates except for highest and lowest risk groups in the control arm. For the weighted
estimator, the 95% CIs generally covers the average model-based estimates except for
the middle risk group in the control arm. We calculated two summary measures of
calibration: average absolute difference between model-based and empirical absolute
risk estimates across five risk groups and O/E ratio. The O/E ratio is defined as the
overall empirical 5-year absolute risk divided by the model-based 5-year absolute risk.
The weighted estimator has smaller absolute differences (0.09% and 0.07%) and bet-
ter O/E ratios (1.08 and 1.00) in both PLCO cohorts than the unweighted estimator
(absolute difference, 0.13% and 0.09%; O/E, 0.86 and 0.94). As the PLCO cohort
has a longer follow-up, we also calculated 10-year risk and the the proposed weighted
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Figure 3: Calibration plots of model-based and empirical absolute risk. Solid line:
average model-based absolute risk in each risk group; Dotdash line (cross): the 95%
CIs (point estimates) of empirical absolute risk in each risk group.
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estimator has a very good calibration (Supplemental Figure S2).
For calibration of the UKB cohorts, the weighted estimator again performs the
best among the three models, with average absolute differences of 0.05%, 0.03% and
0.09%, and O/E ratios of 1.02, 1.03 and 0.89 for England, Scotland and Wales, re-
spectively. The performance of the unweighted estimator is in between the WHI and
weighted estimators. For UKB England cohort, the unweighted estimator is poorly
calibrated with its estimates falling out of the 95% CIs of empirical absolute risk in
the three higher risk groups and the deviation is substantial in the highest risk group.
This highlights the importance of accounting for the potential risk factor distribu-
tion difference if one will re-calibrate the model. These results demonstrate that the
weighted estimator that leverages the summary information about disease incidence
and risk factor distribution has the best performance.
6.3 Sensitivity Analyses
To investigate in-depth the performance of various methods, we used the individual-
level data from the PLCO control arm (PLCO-ctrl) to estimate Λ0(t) for CRC by
the Breslow estimator with β0 obtained from the source WHI data, to serve as the
oracle benchmark (i.e., the truth). We compared six different cumulative baseline
hazard function estimators. Naturally, the Breslow estimator obtained from the WHI
data was served as the base model. For our methods, we had an unweighted and
four different weighted estimators. For the unweighted estimator, the baseline hazard
function was constrained to yield the same CRC risk in the PLCO-ctrl cohort. For
the weighted estimators, we additionally constrained the means of risk factors to be
the same as PLCO-ctrl. Specifically, as Aspirin/NSAIDs use and vegetable intake
have large differences of prevalence between WHI and PLCO-ctrl cohorts, we consid-
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ered using either one or both to construct constraints to understand the incremental
improvement of calibration from incorporating additional summary information. We
also constrained on the mean values of all risk factors.
Figure 4 shows the benchmark and six estimators, across a wide range of age.
From subgraph (1), the weighted estimator constraining on all risk factors performs
best, with its estimates agreeing very well with the benchmark, while the estimator
from WHI data performs the worst and the unweighted estimator is in-between. In
subgraph (2), the weighted estimator with only one risk factor constraint deviates
farther from the benchmark than with two risk factor constraints, but is still closer to
the benchmark than the unweighted estimator. The estimator with the constraints
of two risk factors is almost overlapped with the one using means of all risk fac-
tors, indicating that it is adequate to only put constrains on risk factors that the
distributions are significantly different between the source and target cohorts. Sub-
graphs (3)-(4) show that the benchmark falls within the 95% confidence intervals of
the weighted estimator, but not within that of the unweighted one. As expected, ad-
ditional valid external information helps improve calibration. Interestingly, the 95%
CI of the weighted estimator is close to that of the benchmark Breslow estimator,
suggesting that they are equally efficient. We also calculated the absolute risk esti-
mates incorporating the constraints of all risk factors and they are very similar to the
weighted method with fewer constraints in Figure 3.
To assess the performance of the proposed weighted estimator when the com-
peting risk has the same risk factors as the event of interest in the real data, we
conducted a real-data based simulation study, mimicking two UKB cohorts and two
PLCO cohorts. Specifically, for each cohort, we estimated the prevalences of eight
covariates, the proportional hazards functions of the event of interest and competing
event conditional on these covariates, and the Kaplan-Meier estimator of the censor-
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Figure 4: Comparison of six cumulative baseline hazard estimators. In subgraphs (1)-
(2), the solid line is the benchmark Breslow estimator using the individual-level data
of the PLCO control arm. Note that the two weighted estimators that constrain for
only one covariate are almost overlapped. In subgraphs (3)-(4), the dot-dashed and
dashed lines are point estimates (95% CIs) of the unweighted method and the weighted
method (constraint of Aspirin/NSAIDs use and vegetable intake), respectively. Solid
lines are the benchmark Breslow estimator with 95% CI.
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ing distribution. Some of the risk factors (e.g., BMI and Aspirin/NSAID use) are
strongly associated with both the event of interest and competing event. We then
generated the covariates, time-to-event of interest, time-to-competing event, and cen-
soring time for each individual with the same sample size as each of the cohorts. The
observation time is the earliest age among the three and the indicator records the type
corresponding to this earliest age. The simulation results demonstrate the proposed
weighted estimator has robust and efficient performance, with all the relative bias
below 5% and most of them very close to zero (UK cohorts in Table S12 and PLCO
cohorts in Table S13). The coverage probabilities of 95% CI are all greater than 90%.
In contrast, the Breslow estimator has the largest bias as high as over 200%. The
bias for the unweighted estimator is in between the Breslow and weighted estimators.
7 DISCUSSION
In this article, we present an empirical likelihood-based weighted estimating equation
approach to re-calibrating the risk prediction model developed from one cohort to
another, leveraging the summary-level information from the target population. In
the presence of competing risks, the proposed weighted estimating equation yields
nearly unbiased estimator and valid inference, even if the risk score βTZ for the
event of interest is associated with the competing event. The proposed method offers
a practical and robust solution to re-calibration of baseline risk while accommodating
competing risks.
Like existing approaches, our proposed method imposes the constrain that the
disease incidence rate is consistent to the target population; however, we take an
additional step to reweigh the covariate data from the source study towards a more
representative sample for the target population. This additional step has made our
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estimator much more robust than previously proposed approaches Gail et al. (1989);
Liu et al. (2014). Extensive simulation and real data analyses demonstrate that this
step is critical, and surprisingly, has not been considered in the literature of risk
prediction. While our example cohorts of PLCO and UKB have sufficient individual
level data to build its own prediction model, in practice large research cohorts with
detailed individual data often do not exist and re-calibration with high-level informa-
tion is a much more feasible solution. In addition, compared with model developed
in these cohorts using full individual level data, our approach, even with only limited
cohort information, can yield absolute risk projection that is both well calibrated to
the new cohort and equally efficient. This is very appealing.
Many risk prediction models have been developed based on various research co-
horts. It is of great interest to apply these models to populations beyond the cohorts
that were used for building these models. However, the common approach of apply-
ing these models directly to the target population can lead to non-ignorable over-
or under-estimation of risk due to heterogeneity between source and target cohorts.
This phenomenon occurs frequently in practice but has seldom been dealt with sta-
tistical rigor. We proposed a practical solution to account for this heterogeneity
by synthesizing individual level data from the source cohort and the summary in-
formation from the target population. With the rapidly increasing availability of
summary data in the public domain, auxiliary summary-level information is readily
accessible. For example, cancer incidence rates can be obtained from existing public
resources such as the Surveillance Epidemiology and End Results Registry (SEER)
data (http://www.seer.cancer.gov), which is a primary source for cancer statistics
representing 26% of the U.S. population. For casting risk to a specific population,
exposure and disease prevalence are often reported in historical publications. Further,
the risk factor summary information may be obtained by a small to moderate ran-
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dom sample of the target population without the need of follow-up, which is feasible
regarding time and cost to conduct such a study. In this situation, one can plug them
directly into the estimating equation (4) and obtain the estimate of baseline hazard
by solving the equation. If additional summary information (e.g., summary statistics
of one or two covariates from a much larger sample size) is available, we can further
gain efficiency by using the proposed method through additional constraints.
Regarding which summary statistics for covariates could be most helpful, it de-
pends on the shape of the covariate distribution, as well as the correlations among
covariates. In general, mean and variance are sufficient to capture all the information
if the covariate is normally distributed. For highly skewed covariates or these with
multiple modes, quantiles provide necessarily additional information. If covariates
are strongly correlated, conditional statistics can be helpful. It is worth noting that
auxiliary summary statistics could be from multiple sources with different precision.
After carefully selecting/combining such statistics through balancing their reliability
and precision, the proposed method can synthesize them in an optimal way in terms
of empirical likelihood.
There are a couple of directions that our proposed method can be extended. First,
we use the empirical likelihood approach to impose the equality constraints for re-
weighting the samples. When the auxiliary information has a large variance, the pro-
posed approach, though reduces the bias substantially, can lose efficiency. Inequality
constraints may allow for some trade-off between bias and efficiency. Second, alter-
native approaches such as exponential tilting (Haberman, 1984) and the generalized
empirical likelihood (Newey and Smith, 2004) may generate weights with different
properties (Little and Wu, 1991). These extensions deserve further study but are
beyond the scope of this article.
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Web Appendix A: A List of the Regularity Condi-
tions
In the following sections we establish the large sample results of the proposed estima-
tors and show the consistency and asymptotic normality of Λ̂u0(t) and Λ̂
w
0 (t) under reg-
ularity conditions listed below. We assume the cohort data from P ∗ and the summary
information from P are statistically independent, i.e., (Sˆ(t), µˆ) ⊥ {(Xi, δi,Zi), i =
1, ..., n}.
First we define following notation.
Let s(t) be a generic overall survival function.
Let Σµ,S(t) = limm→∞mE∗{(µˆ− µ0)(Sˆ(t)− S(t))}.
Define Q(Z;γ,µ) = log[1+γT{h(Z)−µ}] ·I[1+γT {h(Z)−µ}>0]−∞·I[1+γT {h(Z)−µ}≤0].
Let γ0 be one solution to maxγ E
∗{Q(Z;γ,µ0)} if at least one solution exists.
Let Λ†0(t) be one solution to E
∗{ρ1(Z;V (t),γ0,µ0, S(t),β0)} = 0.
Let Qγ,γT ,0(Z) ≡ ∂2Q(Z;γ,µ0)/∂γ∂γT |γ=γ0 .
The regularity conditions are listed below.
A1. The regularity conditions to ensure consistency and asymptotic normality of
β̂ under the Cox proportional hazards model: {(Xi, δi,Zi), i = 1, ..., n} are
independently and identically distributed (i.i.d.), and both Li and Ci are in-
dependent of Ti conditional on Zi; Pr(X > τ) > 0, where τ is the maximum
follow-up time; Z is time-independent and bounded; and E∗{n−1I(β0)} is
positive definite, where I(β) = −∂U(β)/∂β.
A2. Sˆ(t) is consistent and asymptotically normal, and its variance estimator is con-
sistent. For Theorem 2 and 3, µ̂’s are consistent and asymptotically normal and
their variance estimators are consistent.
2
A3. The sample sizes satisfy n/m→ r as n→∞ for r > 0.
A4. Let µ ≡ (µ1, ..., µq)T . Let Bj1 ≡ {Z|hj(Z)− µj > 0}, Bj2 ≡ {Z|hj(Z)− µj <
0}, j = 1, ..., q. For each element in {(k1, ..., kq)|kj ∈ {1, 2}}, Pr{∩qj=1Bjkj} > 0
holds. Further, maxγ E
∗{Z;γ,µ0)} <∞.
A5. There exist enough small compact neighborhoods of Λ†0(t), γ0, µ0, S(t) and β0,
denoted as ΘΛ, Θγ , Θµ, ΘS, Θβ, respectively, such that Q(Z;γ,µ) is continu-
ous at each (γ,µ) ∈ Θ′ ≡ Θγ × Θµ and ρ1(Z;V (t),γ,µ, s(t),β) is continuous
at each (V (t),γ,µ, s(t),β) ∈ Θ ≡ ΘΛ × Θγ × Θµ × ΘS × Θβ with probability
one for P ∗.
In addition, there exist functions of Z with finite expectations, dominating the
Euclidean L2 norm of the following functions for any (V (t),γ,µ, s(t),β) ∈ Θ:
Q(Z;γ,µ), ρ1(Z;V (t),γ,µ, s(t),β), ∂
2Q(Z;γ,µ)/∂γ∂γT , ∂2Q(Z;γ,µ)/∂γ∂µT ,
and ∂ρ1(Z;V (t),γ,µ, s(t),β)/∂Rj, j = 1, ..., 5 where R1 = V (t), R2 = γ, R3 =
µ, R4 = s(t) and R5 = β.
A6. Assume σ2ρ ≡ E∗{ρ21(Z; Λ†0(t),γ0,µ0, S(t),β0)} <∞.
Under the condition A1, the coefficients βˆ is consistent to β0 and asymptotically
normal, i.e.,
√
n(βˆ−β0) d−→ N(0,Σβ), where 0 is a p×1 vector with each component
equal to 0. The estimated variance of βˆ, i.e., Σˆβˆ, satisfies that nΣˆβˆ is consistent to
Σβ.
The condition A2 indicates the following results: the auxiliary external informa-
tion Sˆ(t) satisfies
√
m(Sˆ(t)− S(t)) d−→ N(0, σ2S(t)) and the estimated variance of Sˆ(t),
denoted by σˆ2
Sˆ(t)
, satisfies that mσˆ2
Sˆ(t)
is asymptotically consistent to σ2S(t); µˆ is con-
sistent and asymptotically normal, and its variance matrix estimator is consistent.
Then the auxiliary external information µˆ satisfies
√
m(µˆ−µ) d−→ N(0,Σµ) and the
3
estimated variance covariance matrix of µˆ, i.e., Σˆµˆ, satisfies that mΣˆµˆ is consistent
to Σµ.
The condition A4 ensures that with probability approaching one, the zero point
vector is within the convex hull of {h(Zi)− µ, i = 1, ..., n}.
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Theorem 1. Assume the risk factor distributions are common between P and P ∗,
i.e., f(Z) = f ∗(Z). Under regularity conditions A1-A3, Λ̂u0(t) is consistent to Λ0(t),
where Λ0(t) is the true cumulative baseline hazard function in the target population,
and
√
n{Λ̂u0(t)− Λ0(t)} converges to a zero mean normal distribution with variance
σ21(t) = [E
∗{ΦΛ,0(t,Z)}]−2 Π0,
where
Π0 = E
∗{Φ20(t,Z)}+ E∗{Φβ,0(t,Z)}TΣβE∗{Φβ,0(t,Z)}+ rσ2S(t)
+2 lim
n→∞
cov(Π0,1,Π0,2),
Π0,1 =
1√
n
n∑
i=1
Φ0(t,Zi),
Π0,2 = E
∗{Φβ,0(t,Z)}T
√
n(βˆ − β0),
Φ0(t,Z) ≡ Φ(Z; Λ0(t),β0, S(t)),
ΦΛ,0(t,Z) ≡ ∂Φ(Z;V (t),β0, S(t))
∂V (t)
|V=Λ0 ,
Φβ,0(t,Z) ≡ ∂Φ(Z; Λ0(t),β, S0(t))
∂β
|β=β0 .
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Note that
lim
n→∞
cov(Π0,1,Π0,2) = E
∗{Φ0(t,Z)lT (X, δ,Z)Σβ} E∗{Φβ,0(t,Z)} = 0,
where l(X, δ,Z) is the efficient influence function of (X, δ,Z) for βˆ obtained by solving
the score equation of the partial log-likelihood function under the Cox proportional
hazards model.
Proof. Φ(Z;V (t),β, s(t)) is continuous at each (V (t),β, s(t)) ∈ Θ′′ for any Z, and
bounded in Θ
′′
, where Θ
′′
is any compact set satisfying 0 ≤ s(t) ≤ 1 and V (t) ≥ 0.
From Lemma 2.4 in Newey and McFadden (1994), E∗{Φ(Z;V (t),β, s(t))} is con-
tinuous and Φn(V (t),β, s(t)) ≡ n−1
∑n
i=1 Φ(Zi;V (t),β, s(t)) converges uniformly in
probability to E∗{Φ(Z;V (t),β, s(t))} in Θ′′ . With βˆ p−→ β0 and Sˆ(t) p−→ S(t), given a
large positive number M ,
sup
0≤V (t)≤M
‖Φn(V (t), βˆ, Sˆ(t))− E∗{Φ(Z;V (t),β0, S(t))}‖
≤ sup
0≤V (t)≤M
‖Φn(V (t), βˆ, Sˆ(t))− E∗{Φ(Z;V (t), βˆ, Sˆ(t))}‖
+ sup
0≤V (t)≤M
‖E∗{Φ(Z;V (t),β0, S(t))} − E∗{Φ(Z;V (t), βˆ, Sˆ(t))}‖.
Each of the last two terms converges to zero in probability, from the uniform con-
sistency of Φn(V (t),β, s(t)) and the uniform continuity of E
∗{Φ(Z;V (t),β, s(t))}
over Θ
′′
by Heine-Cantor theorem. Since E∗{Φ(Z;V (t),β0, S(t))} is strictly decreas-
ing with respect to V (t), E∗{Φ(Z; 0,β0, S(t))} ≥ 0 and E∗{Φ(Z;∞,β0, S(t))} ≤ 0,
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there exists a unique solution of E∗{Φ(Z;V (t),β0, S(t))} at Λ0(t). We have
‖E∗{Φ(Z; Λ̂u0(t),β0, S(t))} − E∗{Φ(Z; Λ0(t),β0, S(t))}‖
= ‖E∗{Φ(Z; Λ̂u0(t),β0, S(t))}‖
= ‖Φn(Λ̂u0(t), βˆ, Sˆ(t))− E∗{Φ(Z; Λ̂u0(t),β0, S(t))}‖ p−→ 0.
Since E∗{Φ(Z;V (t),β0, S(t))} is a strictly decreasing and continuous function of V ,
by continuous mapping theorem, we have Λ̂u0(t)
p−→ Λ0(t). The consistency of Λ̂u0(t) is
proved.
By Taylor’s expansion, we have
Λ̂u0(t)− Λ0(t) = −(Φn,Λ¯)−1{Φn,0 + Φn,β¯(βˆ − β0)− (Sˆ(t)− S(t))}
where
Φn,0 ≡ n−1
n∑
i=1
Φ0(t,Zi),
Φn,Λ¯ ≡ n−1
n∑
i=1
∂Φ(Zi;V (t), β¯, S¯(t))/∂V (t)|V=Λ¯0 ,
Φn,β¯ ≡ n−1
n∑
i=1
∂Φ(Zi; Λ¯0(t),β, S¯(t))/∂β|β=β¯,
and (Λ¯0(t), β¯, S¯) is a mean value on the line joining (Λ̂
u
0(t), βˆ, Sˆ) and (Λ0(t),β0, S).
Based the boundedness of Z, it is easy to show that Φn,Λ¯ and Φn,β¯ converge in
probability to E∗{ΦΛ,0(t,Z)} and E∗{Φβ,0(t,Z)}, respectively. From the asymptotic
normality of
√
nΦn,0,
√
n(βˆ − β0) and
√
m(Sˆ(t)− S(t)), we have √n(Λ̂u0(t)− Λ0(t))
is asymptotically normal with mean 0 and variances [E∗{ΦΛ,0(t,Z)}]−2 Π0.
6
Web Appendix C: Proof of Theorem 2
Theorem 2. Assume f(Z) = f ∗(Z). Under regularity conditions A1-A5, we have
γ0 = 0 and Λ̂
w
0 (t) is consistent to Λ0(t). With additional condition A6,
√
n{Λ̂w0 (t)−
Λ0(t)} converges to a zero mean normal distribution with variance
σ22(t) = [E
∗{ΦΛ,0(t,Z)}]−2 Π1,
where
Π1 = Π0 − E∗{ρ1,γ,0(t,Z)}T [E∗{Qγ,γT ,0(Z)}]−1E∗{ρ1,γ,0(t,Z)}+ ΠT1,4 rΣµ Π1,4
+ 2cov(Π0,1,Π1,3) + 2 lim
n→∞
cov(Π0,2,Π1,3)− 2ΠT1,4 rΣµ,S(t),
with
Π1,3 = −E∗{ρ1,γ,0(t,Z)}T [E∗{Qγ,γT ,0(Z)}]−1
√
n
n
n∑
i=1
Qγ,0(Zi),
Π1,4 = E
∗{ρ1,µ,0(t,Z)} − E∗{ρ1,γ,0(t,Z)}T [E∗{Qγ,γT ,0(Z)}]−1[E∗{Qγ,µT ,0(Z)}]−1,
ρ1,γ,0(t,Z) ≡ ∂ρ1(Z; Λ0(t),γ,µ0, S(t),β0)
∂γ
|γ=γ0 ,
ρ1,µ,0(t,Z) ≡ ∂ρ1(Z; Λ0(t),γ0,µ, S(t),β0)
∂µ
|µ=µ0 ,
Qγ,γT ,0(Z) ≡
∂2Q(Z;γ,µ0)
∂γ∂γT
|γ=γ0 ,
Qγ,µT ,0(Z) ≡
∂2Q(Z;γ,µ)
∂γ∂µT
|γ=γ0,µ=µ0 ,
Qγ,0(Z) ≡ ∂Q(Z;γ,µ0)
∂γ
|γ=γ0 .
Proof. As this theorem can be seen as a special case of Theorem 3, we omit the proof
here.
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It is easy to show
cov(Π0,1,Π1,3) = E
∗{ρ1,γ,0(t,Z)}T [E∗{Qγ,γT ,0(Z)}]−1E∗{ρ1,γ,0(t,Z)},
lim
n→∞
cov(Π0,2,Π1,3) = E
∗{ρ1,γ,0(t,Z)}T [E∗{Qγ,γT ,0(Z)}]−1
·E∗{Qγ,0(Z)lT (X, δ,Z)} ·ΣβE∗{ρ1,β,0(t,Z)} = 0,
where ρ1,β,0(t,Z) ≡ ∂ρ1(Z; Λ0(t),γ0,µ0, S(t),β)/∂β|β=β0 . From the asymptotic
variance expression, we have σ22(t) < σ
2
1(t) when Π
T
1,4 rΣµ Π1,4 + cov(Π0,1,Π1,3) −
2ΠT1,4 rΣµ,S(t) < 0. When r is low, both Π
T
1,4 rΣµ,S(t) and Π
T
1,4 rΣµ Π1,4 are close
to zero. We show in the following section that E∗{Qγ,γT ,0(Z)} is negative definite.
Its inverse is also negative definite and then cov(Π0,1,Π1,3) < 0. Thus σ
2
2(t) < σ
2
1(t).
Web Appendix D: Proof of Theorem 3
Theorem 3. Under regularity conditions A1-A5, we have Λ̂w0 (t) is consistent to Λ
†
0(t).
With additional condition A6,
√
n{Λ̂w0 (t) − Λ†0(t)} converges to a zero mean normal
distribution with variance
σ23(t) = [E
∗{ρ1,Λ,0(t,Z)}]−2 Π2,
where
Π2 = E
∗{ρ21,0(t,Z)} − E∗{ρ1,γ,0(t,Z)}T [E∗{Qγ,γT ,0(Z)}]−1E∗{ρ1,γ,0(t,Z)}
+ ΠT1,4 rΣµ Π1,4 + E
∗{ρ1,β,0(t,Z)}TΣβE∗{ρ1,β,0(t,Z)}+ rσ2S(t)[E∗{ρ1,S,0(t,Z)}]2
+ 2 lim
n→∞
cov(Π1,1,Π1,2) + 2cov(Π1,1,Π1,3) + 2 lim
n→∞
cov(Π1,2,Π1,3)
+ 2ΠT1,4 rΣµ,S(t)E
∗{ρ1,S,0(t,Z)},
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with
ρ1,0(t,Z) ≡ ρ1(Z; Λ†0(t),γ0,µ0, S(t),β0),
ρ1,Λ,0(t,Z) ≡ ∂ρ1(Z;V (t),γ0,µ0, S(t),β0)
∂V (t)
|V=Λ†0 ,
ρ1,β,0(t,Z) ≡ ∂ρ1(Z; Λ
†
0(t),γ0,µ0, S(t),β)
∂β
|β=β0 ,
ρ1,S,0(t,Z) ≡ ∂ρ1(Z; Λ
†
0(t),γ0,µ0, s(t),β0)
∂s(t)
|s=S,
Π1,1 =
1√
n
n∑
i=1
ρ1,0(t,Zi),
Π1,2 = E
∗{ρ1,β,0(t,Zi)}T
√
n(βˆ − β0).
Proof. First we prove the consistency. We estimate the weights wi by maximizing∑n
i=1 log(wi) subject to the constraints
∑n
i=1 wi = 1 and
∑n
i=1wi{h(Zi) − µˆ} = 0.
Under condition A4, the solution exists with probability approaching one and can
be written as wˆi = n
−1[1 + γˆT{h(Zi) − µˆ}]−1, where γˆ = argmaxγ
∑n
i=1 log[1 +
γˆT{h(Zi)− µˆ}] by convex duality (Owen, 2001).
Let Qn(γ,µ) ≡ n−1
∑n
i=1 Q(Zi;γ,µ). Under the condition A5, from Lemma 2.4
in Newey and McFadden (1994), we have E∗{Q(Z;γ,µ)} is (uniformly) continuous
and sup(γ,µ)∈Θ′ ‖Qn(γ,µ)− E∗{Q(Z;γ,µ)}‖
p−→ 0.
Now we prove the existence of a unique solution to maxγ E
∗{Q(Z;γ,µ0)}. Since
γ 7→ Q(Z;γ,µ0) is concave, so is γ 7→ E∗{Q(Z;γ,µ0)}. Define
Ω ≡ {γ|‖E∗{Q(Z;γ,µ0)}‖ <∞}. From the condition A4, E∗{∂2Q(Z;γ,µ0)/∂γ∂γT}
is negative definite on Ω. Thus γ 7→ E∗{Q(Z;γ,µ0)} is strictly concave on Ω. As
E∗{Q(Z; 0, µ0)} = 0, Ω is non-empty and 0 is an interior point in Ω. It is easy to see
that Ω is a convex and open set. From the condition A4 and the strict concaveness of
γ 7→ E∗{Q(Z;γ,µ0)} on the open convex set Ω, there exits a unique interior solution
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to maxγ E
∗{Q(Z;γ,µ0)}, denoted as γ0. Therefore γ0 must satisfy
E∗{∂Q(Z;γ,µ0)/∂γ|γ=γ0} = 0.
From the uniform consistency ofQn(γ,µ) and the uniform continuity of E
∗{Q(Z;γ,µ)}
on Θ
′
, we have
sup
γ∈Θγ
‖Qn(γ, µˆ)− E∗{Q(Z;γ,µ0)}‖
≤ sup
γ∈Θγ
‖Qn(γ, µˆ)− E∗{Q(Z;γ, µˆ)}‖+ sup
γ∈Θγ
‖E∗{Q(Z;γ, µˆ)} − E∗{Q(Z;γ,µ0)}‖
p−→ 0.
Then we have
E∗{Q(Z; γˆ, µ0)} − E∗{Q(Z;γ0, µ0)}
= Qn(γˆ, µˆ) + op(1)− E∗{Q(Z;γ0, µ0)}
≥ Qn(γ0, µˆ) + op(1)− E∗{Q(Z;γ0, µ0)}
= E∗{Q(Z;γ0, µˆ)}+ op(1)− E∗{Q(Z;γ0, µ0)}
= op(1).
Now E∗{Q(Z; γˆ, µ0)} ≥ E∗{Q(Z;γ0, µ0)} + op(1). As γ0 is the unique solution of
maxγ E
∗{Q(Z;γ,µ0)} and Θγ is compact, we have γˆ p−→ γ0.
Now we prove that there exists a unique solution to ρ01(t, V ) ≡
E∗{ρ1(Z;V (t),γ0,µ0, S(t),β0)} = 0. Let the solution be Λ†0(t). ρ01(t, V ) is contin-
uous and strictly decreasing on any non-negative compact set, since 1 + γT0 {h(Z)−
µ0} > 0 with probability one for P ∗, Φ(Z;V (t),β0, S(t)) is bounded, continuous and
strictly decreasing for V (t), limV (t)→0 Φ(Z;V (t),β0, S(t)) > 0, limV (t)→∞Φ(Z;V (t),β0, S(t)) <
0. Then there is a unique solution to ρ01(t, V ) = 0, and (γˆ, Λ̂
w
0 (t)) exist with proba-
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bility approaching one.
Let ρn1(V (t),γ,µ, s(t),β) ≡ n−1
∑n
i=1 ρ1(Zi;V (t),γ,µ, s(t),β). Under the con-
dition A5, using Lemma 2.4 in Newey and McFadden (1994), we have E∗{ρ1(Z;V (t),γ,µ, s(t),β)}
is (uniformly) continuous and
sup
(V (t),γ,µ,s(t),β)∈Θ
‖ρn1(V (t),γ,µ, s(t),β)− E∗{ρ1(Z;V (t),γ,µ, s(t),β)}‖ p−→ 0.
By the uniform consistency of ρn1(V (t),γ,µ, s(t),β) on Θ, γˆ
p−→ γ0, βˆ p−→ β0,
µˆ
p−→ µ0 and Sˆ(t) p−→ S(t), we have
sup
V (t)∈ΘΛ
‖ρn1(V (t), γˆ, µˆ, Sˆ(t), βˆ)− ρ01(t, V )‖
≤ sup
V (t)∈ΘΛ
‖ρn1(V (t), γˆ, µˆ, Sˆ(t), βˆ)− E∗{ρ1(Z;V (t), γˆ, µˆ, Sˆ(t), βˆ)}‖
+ sup
V (t)∈ΘΛ
‖E∗{ρ1(Z;V (t), γˆ, µˆ, Sˆ(t), βˆ)} − ρ01(t, V )‖.
Each of the last two terms converges to 0 in probability, from the uniform consistency
of ρn1(V (t),γ,µ, s(t),β) and the uniform continuity of E
∗{ρ1(Z;V (t),γ,µ, s(t),β)}
over Θ by Heine-Cantor theorem. Then we have ‖ρ01(t, Λ̂w0 )−ρ01(t,Λ†0)‖ = ‖ρ01(t, Λ̂w0 )‖ =
‖ρ01(t, Λ̂w0 )− ρn1(Λ̂w0 (t), γˆ, µˆ, Sˆ(t), βˆ)‖ p−→ 0. From the existence of a unique solution
Λ†0(t) to ρ01(t, V ) = 0, and the compactness of ΘΛ, we have Λ̂
w
0 (t)
p−→ Λ†0(t). The
consistency of Λ̂w0 (t) is proved.
Define f †(Z) ≡ f ∗(Z)/[1+γT0 {h(Z)−µ0}]. Since 1+γT0 {h(Z)−µ0} > 0, a.s.,
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and
1 =
∫
f ∗(Z)dZ ≡
∫
[1 + γT0 {h(Z)− µ0}]f †(Z)dZ
=
∫
f †(Z)dZ +
∫
γT0 {h(Z)− µ0}f †(Z)dZ
=
∫
f †(Z)dZ + γT0
∫ {h(Z)− µ0}
1 + γT0 {h(Z)− µ0}
f ∗(Z)dZ
=
∫
f †(Z)dZ + γT0 E
∗{∂Q(Z;γ,µ0)/∂γ|γ=γ0}
=
∫
f †(Z)dZ + γT0 0 =
∫
f †(Z)dZ
f †(Z) is a valid probability density function for Z. In addition,
E∗{ρ1(Z;V (t),γ0,µ0, S(t),β0)}
=
∫
ρ1(Z;V (t),γ0,µ0, S(t),β0)f
∗(Z)dZ
=
∫
Φ(Z;V (t),β0, S(t))
1 + γT0 {h(Z)− µ0}
f ∗(Z)dZ
=
∫
Φ(Z;V (t),β0, S(t))
f ∗(Z)dZ
1 + γT0 {h(Z)− µ0}
=
∫
Φ(Z;V (t),β0, S(t))f
†(Z)dZ
= E†{Φ(Z;V (t),β0, S(t))},
where E† is the expectation of Z with respect to the probability density function
f †(Z). Then Λ†0(t) is also the unique solution to E
†{Φ(Z;V (t),β0, S(t))} = 0. Note
that under the conditions of Theorem 2, γ0 = 0 and Λ
†
0(t) = Λ0(t).
Now we prove the asymptotic normality.
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By Taylor-series expansion, we have
0 = ρn1(Λ̂
w
0 (t), γˆ, µˆ, Sˆ(t), βˆ)
= ρn1(Λ
†
0(t),γ0,µ0, S(t),β0) + ρn1,Λ¯(Λ̂
w
0 (t)− Λ†0(t)) + ρn1,γ¯(γˆ − γ0)
+ρn1,µ¯(µˆ− µ0) + ρn1,S¯{Sˆ(t)− S(t)}+ ρn1,β¯(βˆ − β0),
0 = ∂Qn(γ,µ)/∂γ|(γ,µ)=(γˆ,µˆ)
= ∂Qn(γ,µ)/∂γ|(γ,µ)=(γ0,µ0) +Qn,γ¯,γ¯T (γˆ − γ0) +Qn,γ¯,µ¯T (µˆ− µ0)
where
ρn1,Λ¯ = ∂ρn1(V (t),γ,µ, s(t),β)/∂V (t)|(V,γ,µ,s,β)=(Λ¯0,γ¯,µ¯,S¯,β¯),
ρn1,γ¯ = ∂ρn1(V (t),γ,µ, s(t),β)/∂γ|(V,γ,µ,s,β)=(Λ¯0,γ¯,µ¯,S¯,β¯),
ρn1,µ¯ = ∂ρn1(V (t),γ,µ, s(t),β)/∂µ|(V,γ,µ,s,β)=(Λ¯0,γ¯,µ¯,S¯,β¯),
ρn1,S¯ = ∂ρn1(V (t),γ,µ, s(t),β)/∂s(t)|(V,γ,µ,s,β)=(Λ¯0,γ¯,µ¯,S¯,β¯),
ρn1,β¯ = ∂ρn1(V (t),γ,µ, s(t),β)/∂β|(V,γ,µ,s,β)=(Λ¯0,γ¯,µ¯,S¯,β¯),
Qn,γ¯,γ¯T = ∂
2Qn(γ,µ)/∂γ∂γ
T |(γ,µ)=(γ¯,µ¯),
Qn,γ¯,µ¯T = ∂
2Qn(γ,µ)/∂γ∂µ
T |(γ,µ)=(γ¯,µ¯),
(Λ¯0(t), γ¯, µ¯, S¯(t), β¯) is a mean value on the line joining (Λ
†
0(t),γ0,µ0, S(t),β0) and
(Λ̂w0 (t), γˆ, µˆ, Sˆ(t), βˆ). Then we have
γˆ − γ0 = −Q−1n,γ¯,γ¯T {∂Qn(γ,µ)/∂γ|(γ,µ)=(γ0,µ0) +Qn,γ¯,µ¯T (µˆ− µ0)},
Λ̂w0 (t)− Λ†0(t) = −ρ−1n1,Λ¯{ρn1(Λ†0(t),γ0,µ0, S(t),β0) + ρn1,γ¯(γˆ − γ0)
+ρn1,µ¯(µˆ− µ0) + ρn1,S¯{Sˆ(t)− S(t)}+ ρn1,β¯(βˆ − β0)}.
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Reorganizing the two equations, we have
Λ̂w0 (t)− Λ†0(t) (A.1)
= −ρ−1
n1,Λ¯
[ρn1(Λ
†
0(t),γ0,µ0, S(t),β0) + ρn1,µ¯(µˆ− µ0) + ρn1,S¯{Sˆ(t)− S(t)}
−ρn1,γ¯Q−1n,γ¯,γ¯T {∂Qn(γ,µ)/∂γ|(γ,µ)=(γ0,µ0) +Qn,γ¯,µ¯T (µˆ− µ0)}+ ρn1,β¯(βˆ − β0)].
By the condition A5, using Lemma 2.4 in Newey and McFadden (1994), we have
ρn1,Λ¯
p−→ E∗{ρ1,Λ,0(t,Z)},
ρn1,γ¯
p−→ E∗{ρ1,γ,0(t,Z)},
ρn1,µ¯
p−→ E∗{ρ1,µ,0(t,Z)},
ρn1,S¯
p−→ E∗{ρ1,S,0(t,Z)},
ρn1,β¯
p−→ E∗{ρ1,β,0(t,Z)},
Qn,γ¯,γ¯T
p−→ E∗{Qγ,γT ,0(Z)},
Qn,γ¯,µ¯T
p−→ E∗{Qγ,µT ,0(Z)}.
E∗{Qγ,γT ,0(Z)} is negative definite and E∗{ρ1,Λ,0(t,Z)} < 0. With the condition
A1 and A2, we have
√
n(βˆ − β0),
√
m{Sˆ(t) − S(t)} and √m(µˆ − µ0) are asymp-
totically normal. Under the condition A5 and A6, using the central limit theorem,
√
nρn1(Λ
†
0(t),γ0,µ0, S(t),β0) and
√
n∂Qn(t,γ,µ)/∂γ|(γ,µ)=(γ0,µ0) are asymptotically
normal. With the condition A3, from (A.1),
√
n{Λ̂w0 (t) − Λ†0(t)} is asymptotically
normal with mean 0 and variance [E∗{ρ1,Λ,0(t,Z)}]−2 Π2.
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It is easy to show
lim
n→∞
cov(Π1,1,Π1,2) = lim
n→∞
E∗{n−1
n∑
i=1
ρ1,0(t,Zi)l
T (Xi, δi,Zi)Σβ} E∗{ρ1,β,0(t,Z)}
= E∗{ρ1,0(t,Z)lT (X, δ,Z)}Σβ E∗{ρ1,β,0(t,Z)} = 0,
cov(Π1,1,Π1,3) = E
∗{ρ1,γ,0(t,Z)}T [E∗{Qγ,γT ,0(Z)}]−1E∗{ρ1,γ,0(t,Z)},
lim
n→∞
cov(Π1,2,Π1,3) = E
∗{ρ1,γ,0(t,Z)}T [E∗{Qγ,γT ,0(Z)}]−1
·E∗{Qγ,0(Z)lT (X, δ,Z)} ·ΣβE∗{ρ1,β,0(t,Z)} = 0.
Now we briefly show the derivation of the asymptotic-based variance estimator
of the absolute risk. The estimate of the absolute risk Pr(t0 < T ≤ t1,∆ = 1|T >
t0,Z) =
∫ t1
t0
λ(u|Z) exp[− ∫ u
t0
{λ(s|Z) + λc(s|Z)}ds]du can be written as a sum over
the distinct times u1, u2, ..., uL for event of interest occurring within [t0, t1], as
P̂r(t0 < T ≤ t1,∆ = 1|T > t0,Z)
=
L∑
l=1
λ̂(ul|Z) exp
[
−{Λ̂(ul|Z)− Λ̂(t0|Z)} − {Λ̂c(ul|Z)− Λ̂c(t0|Z)}
]
=
L∑
l=1
λ̂0(ul) exp (β̂
TZ) exp
[
−{Λ̂0(ul)− Λ̂0(t0)} exp (β̂TZ)− {Λ̂c(ul|Z)− Λ̂c(t0|Z)}
]
=
L∑
l=1
{Λ̂0(ul+1)− Λ̂0(ul)} exp (β̂TZ) · exp
[
−{Λ̂0(ul)− Λ̂0(t0)} exp (β̂TZ)− {Λ̂c(ul|Z)− Λ̂c(t0|Z)}
]
where Λ̂c(t|Z) is the hazard function estimate of the competing event at age t given
Z with respect to the target population.
Due to practical limitation of data availability, one often ignores covariates and
sets the competing risk to be independent with covariates in calculating the absolute
risk. This is often a good approximation, because allowing covariates in modelling
the competing risk may have little impact on estimates of the absolute risk of the
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event of interest (see discussion in Chapter 5.4 in Pfeiffer and Gail (2017) and Section
5 in Liu et al. (2014)). Under this approximation, the absolute risk estimate can be
written as
P̂r(t0 < T ≤ t1,∆ = 1|T > t0,Z)
=
L∑
l=1
{Λ̂0(ul+1)− Λ̂0(ul)} exp (β̂TZ) · exp
[
−{Λ̂0(ul)− Λ̂0(t0)} exp (β̂TZ)− {Λ̂c(ul)− Λ̂c(t0)}
]
where Λ̂c(t) is the overall hazard function estimate of the competing event at age
t with respect to the target population. Let us denote Ξ = (βT0 ,Λ0(ul),Λc(ul), l =
1, ..., L)T and Ξ̂ = (βˆT , Λ̂0(ul), Λ̂c(ul), l = 1, ..., L)
T . The absolute risk estimator
P̂r(t0 < T ≤ t1,∆ = 1|T > t0,Z) is a function of (Z; Ξ̂), denoted as f(Z; Ξ̂). By the
first order expansion, we have f(Z; Ξ̂) ≈ f(Z; Ξ)+fTΞ (Z; Ξ̂)(Ξ̂−Ξ) where fΞ(Z; Ξ̂)
is the derivative vector of the function f(Z; Ξ) with respect to Ξ at Ξ = Ξ̂. By
the delta method, we have the variance estimator of f(Z; Ξ̂) as fTΞ (Z; Ξ̂)v̂ar(Ξ̂ −
Ξ)fΞ(Z; Ξ̂), where v̂ar(Ξ̂ − Ξ) is the estimate of variance-covariance matrix of
Ξ̂ − Ξ. To calculate v̂ar(Ξ̂ − Ξ), we need the variances var(βˆ) and var(Λ̂c(ul)), l =
1, ..., L that are readily available, and var(Λ̂0(ul)), l = 1, ..., L that can be obtained
by the above asymptotic results. We also need the covariances cov(βˆ, Λ̂0(ul)), l =
1, ..., L and cov(Λ̂0(uj)), Λ̂0(ul)), j, l = 1, ..., L that can be easily derived with a
similar process as in the proof of Theorem 3. Note that cov(Λ̂0(uj)), Λ̂c(ul)) and
cov(Λ̂c(uj)), Λ̂c(ul)), j, l = 1, ..., L are generally not available and we can set them as
0 in the calculation.
In some application, where the hazard of competing event is high and strongly
associated with covariates of event of interest, it is essential to include covariates in
modelling the competing risk for absolute risk calculation. Since the competing event
is not uncommon, the information of covariate-specific competing risk model may be
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available for the target population. By incorporating these information, the absolute
risk and its variance, can be similarly derived as described above.
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Web Appendix E: the Connection to the Attributable
Hazard Function
In this section we show that for a general hazard function, the proposed estimating
equation can be seen as an integral form of the attributable hazard function.
Let λ(t|Z(t)) be a general hazard function given a time-varying risk profile Z(t)
at time t. Let Z¯ represent the entire risk profile history {Z(t), t ≥ 0}. The sur-
vival function given Z¯ is then S(t|Z¯) = exp{− ∫ t
0
λ(t|Z(u))du} and the overall sur-
vival function is S(t) = exp{− ∫ t
0
λ(u)du}, where the overall hazard function λ(t) =
EZ¯{S(u|Z¯)λ(t|Z(t))}/EZ¯{S(u|Z¯)} = {
∫
Z¯
S(u|Z¯)λ(t|Z(t))f(Z¯)dZ¯}/{∫
Z¯
S(u|Z¯)f(Z¯)dZ¯}
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and f(Z¯) is the probability density function of Z¯. Let λ0(t) ≡ λ(t|Z(t) = 0) be
the baseline hazard function and the time-varying hazard ratio function η(t,Z(t)) ≡
λ(t|Z(t))/λ0(t). Our proposed estimating equation has the general form of EZ¯{S(t|Z¯)} =
S(t). Taking the derivative of both sides with respect to t, we have
∂EZ¯{S(t|Z¯)}
∂t
=
∂S(t)
∂t
⇔ EZ¯{
∂S(t|Z¯)
∂t
} = −λ(t)S(t)
⇔
∫
Z¯
exp{−
∫ t
0
λ(t|Z(u))du}{−λ(t|Z(t))}f(Z¯)dZ¯ = −λ(t)S(t)
⇔
∫
Z¯
exp{−
∫ t
0
λ(t|Z(u))du}λ0(t)η(t,Z(t))f(Z¯)dZ¯ = λ(t)S(t)
⇔ λ0(t)
λ(t)
=
S(t)∫
Z¯
exp{− ∫ t
0
λ(t|Z(u))du}η(t,Z(t))f(Z¯)dZ¯ =
S(t)
EZ¯{S(t|Z¯)η(t|Z(t))}
(A.2)
Note that the attributable hazard function
AR(t) =
λ(t)− λ0(t)
λ(t)
= 1− λ0(t)
λ(t)
= 1− λ0(t)
EZ¯{S(t|Z¯)λ(t|Z(t))}/EZ¯{S(t|Z¯)}
= 1− λ0(t)
EZ¯{S(t|Z¯)λ(t|Z(t))}/S(t)
= 1− S(t)
EZ¯{S(t|Z¯)η(t|Z(t))}
and then 1 − AR(t) = S(t)/EZ¯{S(t|Z¯)η(t|Z(t))}. Thus (A.2) is equivalent to
λ0(t)/λ(t) = 1− AR(t).
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Web Appendix F: Short list of the Women’s Health
Initiative (WHI) Investigators
Program Office: (National Heart, Lung, and Blood Institute, Bethesda, Maryland)
Jacques Rossouw, Shari Ludlam, Joan McGowan, Leslie Ford, and Nancy Geller
Clinical Coordinating Center: (Fred Hutchinson Cancer Research Center, Seattle,
WA) Garnet Anderson, Ross Prentice, Andrea LaCroix, and Charles Kooperberg
Investigators and Academic Centers: (Brigham and Women’s Hospital, Harvard
Medical School, Boston, MA) JoAnn E. Manson; (MedStar Health Research Insti-
tute/Howard University, Washington, DC) Barbara V. Howard; (Stanford Preven-
tion Research Center, Stanford, CA) Marcia L. Stefanick; (The Ohio State Univer-
sity, Columbus, OH) Rebecca Jackson; (University of Arizona, Tucson/Phoenix, AZ)
Cynthia A. Thomson; (University at Buffalo, Buffalo, NY) Jean Wactawski-Wende;
(University of Florida, Gainesville/Jacksonville, FL) Marian Limacher; (University
of Iowa, Iowa City/Davenport, IA) Jennifer Robinson; (University of Pittsburgh,
Pittsburgh, PA) Lewis Kuller; (Wake Forest University School of Medicine, Winston-
Salem, NC) Sally Shumaker; (University of Nevada, Reno, NV) Robert Brunner
Womens Health Initiative Memory Study: (Wake Forest University School of
Medicine, Winston-Salem, NC) Mark Espeland
For a list of all the investigators who have contributed to WHI science, please visit:
https://www.whi.org/researchers/Documents%20%20Write%20a%20Paper/WHI%20
Investigator%20Long%20List.pdf
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Web Appendix G: Supplementary Results for the
Simulation Studies
In this section, we provide the simulation results under a variety of settings that
can not be accommodated in the main article due to space constraint. This includes
Table S1 - S3 for when the sample size used to calculate the summary statistics is
large (m = 100,000), Table S4 - S7 when m = 1,000, and Table S8 - S11 when m
= 200, representing the precision of summary statistics information high, moderate,
and low, respectively. Under each sample size configuration, we also evaluated the
performance of various methods when the baseline hazard function from the target
population differs from the source study that was used for developing the risk pre-
diction model with varying degree. The results are similar to what is presented in
the main article. We also calculated the asymptotic-based standard error assuming
known off-diagonal elements of Σˆµˆ, to accommodate the situation that covariance be-
tween the moments may be available. The corresponding asymptotic-based standard
error and 95%coverage probability are denoted by ASEd and CPd. These estimates
are nearly identical to those assuming covariance equal to 0.
In addition, we provide the results for the calibration of 10-year absolute risk in
the real example in Figure S2 and the results of real data-based simulation in the
presence of competing risks in Table S12 and S13.
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Table S1: Summary statistics of simulation results for the scenario of m = 100, 000,
(A1)/(A2), and n = 1, 000.
(A1) Λ∗0(t) = Λ0(t) = (0.01t)
2
(C1) Z1 ∼ Bernoulli(0.5), Z2 ∼ N(0, 1), (C2) Z1 ∼ Bernoulli(0.8), Z2 ∼ N(0, 1),
and Z1 ⊥ Z2, i.e., f∗(Z1, Z2) = f(Z1, Z2) and Z1 ⊥ Z2
t Λ0(t) Λ̂b0(t) Λ̂
u
0(t) Λ̂
w
0,1(t) Λ̂
w
0,2(t) Λ̂
w
0,3(t) Λ̂
w
0,4(t) Λ̂
b
0(t) Λ̂
u
0(t) Λ̂
w
0,1(t) Λ̂
w
0,2(t) Λ̂
w
0,3(t) Λ̂
w
0,4(t)
20 0.04 ASEd 0.65 0.47 0.46 0.43 0.42 0.42 0.65 0.57 0.59 0.55 0.54 0.54
ASE 0.46 0.43 0.42 0.42 0.59 0.55 0.54 0.54
40 0.16 ASEd 1.87 1.64 1.56 1.47 1.45 1.43 1.87 1.94 2.12 2.00 1.98 1.98
ASE 1.56 1.47 1.45 1.43 2.12 2.00 1.98 1.98
60 0.37 ASEd 4.22 3.16 2.97 2.80 2.79 2.77 4.24 3.71 4.38 4.16 4.15 4.14
ASE 2.97 2.80 2.79 2.77 4.38 4.16 4.15 4.14
(C3) Z1 ∼ Bernoulli(0.5), (C4) Z1 ∼ Bernoulli(0.8),
Z2|Z1=1 ∼ N(0.5, 1.2), Z2|Z1=1 ∼ N(0.5, 1.2),
and Z2|Z1=0 ∼ N(−0.5, 0.8) and Z2|Z1=0 ∼ N(−0.5, 0.8)
t Λ0(t) Λ̂b0(t) Λ̂
u
0(t) Λ̂
w
0,1(t) Λ̂
w
0,2(t) Λ̂
w
0,3(t) Λ̂
w
0,4(t) Λ̂
b
0(t) Λ̂
u
0(t) Λ̂
w
0,1(t) Λ̂
w
0,2(t) Λ̂
w
0,3(t) Λ̂
w
0,4(t)
20 0.04 ASEd 0.64 0.57 0.55 0.51 0.50 0.54 0.65 0.79 0.82 0.65 0.64 0.65
ASE 0.55 0.51 0.50 0.54 0.82 0.65 0.64 0.65
40 0.16 ASEd 1.87 1.79 1.71 1.60 1.57 1.67 1.86 2.46 2.75 2.20 2.17 2.21
ASE 1.71 1.60 1.57 1.67 2.75 2.20 2.17 2.21
60 0.37 ASEd 4.24 3.21 3.01 2.84 2.81 2.91 4.24 4.36 5.27 4.26 4.26 4.34
ASE 3.01 2.84 2.81 2.91 5.27 4.26 4.26 4.34
(A2) Λ0(t) = (0.01t)2 and Λ∗0(t) = (0.01t)
1.5
(C1) Z1 ∼ Bernoulli(0.5), Z2 ∼ N(0, 1), (C2) Z1 ∼ Bernoulli(0.8), Z2 ∼ N(0, 1),
and Z1 ⊥ Z2, i.e., f∗(Z1, Z2) = f(Z1, Z2) and Z1 ⊥ Z2
t Λ0(t) Λ̂b0(t) Λ̂
u
0(t) Λ̂
w
0,1(t) Λ̂
w
0,2(t) Λ̂
w
0,3(t) Λ̂
w
0,4(t) Λ̂
b
0(t) Λ̂
u
0(t) Λ̂
w
0,1(t) Λ̂
w
0,2(t) Λ̂
w
0,3(t) Λ̂
w
0,4(t)
20 0.04 ASEd 1.08 0.43 0.41 0.38 0.37 0.36 1.08 0.51 0.52 0.47 0.47 0.46
ASE 0.41 0.38 0.37 0.36 0.52 0.47 0.47 0.46
40 0.16 ASEd 2.44 1.47 1.38 1.27 1.26 1.24 2.45 1.73 1.86 1.72 1.71 1.70
ASE 1.38 1.27 1.26 1.24 1.86 1.72 1.71 1.70
60 0.37 ASEd 4.78 2.83 2.61 2.41 2.41 2.39 4.77 3.31 3.82 3.56 3.56 3.55
ASE 2.61 2.41 2.41 2.39 3.82 3.56 3.56 3.55
(C3) Z1 ∼ Bernoulli(0.5), (C4) Z1 ∼ Bernoulli(0.8),
Z2|Z1=1 ∼ N(0.5, 1.2), Z2|Z1=1 ∼ N(0.5, 1.2),
and Z2|Z1=0 ∼ N(−0.5, 0.8) and Z2|Z1=0 ∼ N(−0.5, 0.8)
t Λ0(t) Λ̂b0(t) Λ̂
u
0(t) Λ̂
w
0,1(t) Λ̂
w
0,2(t) Λ̂
w
0,3(t) Λ̂
w
0,4(t) Λ̂
b
0(t) Λ̂
u
0(t) Λ̂
w
0,1(t) Λ̂
w
0,2(t) Λ̂
w
0,3(t) Λ̂
w
0,4(t)
20 0.04 ASEd 1.08 0.51 0.48 0.45 0.44 0.47 1.08 0.71 0.72 0.56 0.55 0.56
ASE 0.48 0.45 0.44 0.47 0.72 0.56 0.55 0.56
40 0.16 ASEd 2.45 1.61 1.51 1.39 1.36 1.44 2.44 2.20 2.41 1.90 1.87 1.90
ASE 1.51 1.39 1.36 1.44 2.41 1.89 1.87 1.90
60 0.37 ASEd 4.78 2.87 2.65 2.45 2.43 2.50 4.77 3.89 4.60 3.67 3.67 3.73
ASE 2.65 2.45 2.43 2.50 4.60 3.67 3.67 3.73
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Table S2: Summary statistics of simulation results for the scenario of m = 100, 000,
(A3) Λ0(t) = (0.01t)
2 and Λ∗0(t) = (0.008t)
2, and n = 1, 000.
(C1) Z1 ∼ Bernoulli(0.5), Z2 ∼ N(0, 1), (C2) Z1 ∼ Bernoulli(0.8), Z2 ∼ N(0, 1),
and Z1 ⊥ Z2, i.e., f∗(Z1, Z2) = f(Z1, Z2) and Z1 ⊥ Z2
t Λ0(t) Λ̂b0(t) Λ̂
u
0(t) Λ̂
w
0,1(t) Λ̂
w
0,2(t) Λ̂
w
0,3(t) Λ̂
w
0,4(t) Λ̂
b
0(t) Λ̂
u
0(t) Λ̂
w
0,1(t) Λ̂
w
0,2(t) Λ̂
w
0,3(t) Λ̂
w
0,4(t)
20 0.04 PBias -35.7% 1.3% 1.3% 1.3% 1.2% 1.2% -36.0% 21.8% 2.8% 1.9% 1.9% 2.0%
ESD 0.51 0.51 0.51 0.50 0.50 0.50 0.50 0.60 0.67 0.64 0.64 0.64
ASEd 0.51 0.54 0.53 0.50 0.50 0.49 0.50 0.65 0.68 0.65 0.64 0.64
ASE 0.53 0.50 0.50 0.49 0.68 0.65 0.64 0.64
sMSE 1.58 0.51 0.51 0.51 0.50 0.50 1.59 1.10 0.68 0.64 0.64 0.64
CPd 20.3% 95.9% 95.6% 94.9% 94.7% 94.4% 21.1% 75.6% 94.9% 95.1% 95.0% 94.9%
CP 95.6% 94.9% 94.7% 94.4% 94.9% 95.1% 95.0% 94.9%
40 0.16 PBias -0.37% 1.1% 1.1% 1.1% 1.1% 1.0% -36.7% 23.0% 2.8% 2.0% 2.0% 2.0%
ESD 1.47 1.78 1.77 1.74 1.74 1.73 1.43 2.07 2.47 2.34 2.34 2.34
ASEd 1.45 1.88 1.81 1.73 1.72 1.70 1.45 2.22 2.48 2.37 2.36 2.35
ASE 1.81 1.73 1.72 1.70 2.48 2.37 2.36 2.35
sMSE 6.18 1.79 1.78 1.75 1.74 1.74 6.19 4.31 2.51 2.36 2.36 2.37
CPd 4.2% 95.8% 95.3% 94.7% 94.3% 94.0% 3.7% 62.7% 94.0% 95.0% 95.1% 95.0%
CP 95.3% 94.7% 94.3% 94.0% 94.0% 95.0% 95.1% 95.0%
60 0.37 PBias -37.7% 1.0% 1.0% 0.9% 0.9% 0.9% -38.0% 24.3% 2.9% 2.0% 2.0% 2.0%
ESD 3.26 3.49 3.46 3.38 3.38 3.37 3.17 4.03 5.22 4.91 4.91 4.92
ASEd 3.21 3.63 3.46 3.31 3.31 3.29 3.19 4.26 5.14 4.96 4.95 4.94
ASE 3.46 3.31 3.31 3.29 5.14 4.96 4.95 4.94
sMSE 14.17 3.51 3.48 3.40 3.39 3.39 14.25 9.76 5.32 4.97 4.97 4.98
CPd 3.6% 95.8% 95.3% 94.3% 94.2% 94.1% 3.1% 45.0% 93.3% 95.3% 95.2% 95.1%
CP 95.3% 94.3% 94.2% 94.1% 93.3% 95.3% 95.2% 95.1%
CAD 2.80 0.63 0.63 0.61 0.61 0.61 2.80 1.79 0.90 0.85 0.85 0.85
(C3) Z1 ∼ Bernoulli(0.5), (C4) Z1 ∼ Bernoulli(0.8),
Z2|Z1=1 ∼ N(0.5, 1.2), Z2|Z1=1 ∼ N(0.5, 1.2),
and Z2|Z1=0 ∼ N(−0.5, 0.8) and Z2|Z1=0 ∼ N(−0.5, 0.8)
t Λ0(t) Λ̂b0(t) Λ̂
u
0(t) Λ̂
w
0,1(t) Λ̂
w
0,2(t) Λ̂
w
0,3(t) Λ̂
w
0,4(t) Λ̂
b
0(t) Λ̂
u
0(t) Λ̂
w
0,1(t) Λ̂
w
0,2(t) Λ̂
w
0,3(t) Λ̂
w
0,4(t)
20 0.04 PBias -35.8% 22.2% 22.2% 22.1% 15.2% 0.7% -36.3% 73.0% 45.8% 12.3% 4.7% 1.2%
ESD 0.50 0.61 0.61 0.60 0.59 0.65 0.49 0.83 0.95 0.78 0.77 0.77
ASEd 0.50 0.65 0.63 0.60 0.59 0.64 0.50 0.90 0.96 0.77 0.76 0.76
ASE 0.63 0.60 0.59 0.64 0.96 0.77 0.76 0.76
sMSE 1.58 1.11 1.11 1.10 0.87 0.65 1.60 3.18 2.15 0.94 0.79 0.77
CPd 20.5% 75.1% 72.6% 69.6% 84.2% 94.5% 18.9% 3.5% 51.5% 93.9% 95.4% 94.7%
CP 72.6% 69.6% 84.2% 94.5% 51.5% 93.9% 95.4% 94.7%
40 0.16 PBias -36.5% 12.2% 12.3% 12.1% 8.3% 1.6% -36.9% 63.6% 36.4% 7.7% 5.4% 2.6%
ESD 1.48 1.94 1.93 1.89 1.86 2.01 1.45 2.64 3.28 2.63 2.61 2.63
ASEd 1.45 2.05 1.98 1.89 1.85 1.97 1.44 2.81 3.21 2.61 2.57 2.61
ASE 1.98 1.89 1.85 1.97 3.21 2.61 2.57 2.61
sMSE 6.17 2.79 2.79 2.74 2.30 2.03 6.23 10.76 6.81 2.92 2.75 2.67
CPd 4.0% 87.6% 86.3% 84.6% 90.8% 94.7% 3.5% 1.4% 59.5% 95.1% 95.5% 94.7%
CP 86.3% 84.6% 90.8% 94.7% 59.5% 95.1% 95.5% 94.7%
60 0.37 PBias -37.8% 3.0% 3.1% 3.0% 1.5% 2.0% -37.9% 54.1% 27.1% 2.5% 4.2% 3.3%
ESD 3.33 3.52 3.50 3.39 3.35 3.49 3.11 4.84 6.54 5.14 5.18 5.26
ASEd 3.21 3.69 3.52 3.37 3.33 3.46 3.20 5.01 6.21 5.06 5.07 5.17
ASE 3.52 3.37 3.32 3.46 6.21 5.06 5.07 5.17
sMSE 14.21 3.70 3.68 3.56 3.39 3.57 14.22 20.37 11.88 5.22 5.41 5.40
CPd 3.8% 95.7% 94.7% 94.5% 95.3% 94.9% 2.5% 0.4% 70.7% 94.8% 95.2% 94.8%
CP 94.7% 94.5% 95.3% 94.9% 70.7% 94.8% 95.2% 94.8%
CAD 2.79 0.94 0.94 0.93 0.77 0.70 2.82 4.62 2.59 0.99 0.95 0.94
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Table S3: Summary statistics of simulation results for the scenario of m = 100, 000,
(A4) Λ0(t) = (0.01t)
2 and Λ∗0(t) = (0.008t)
1.5, and n = 1, 000.
(C1) Z1 ∼ Bernoulli(0.5), Z2 ∼ N(0, 1), (C2) Z1 ∼ Bernoulli(0.8), Z2 ∼ N(0, 1),
and Z1 ⊥ Z2, i.e., f∗(Z1, Z2) = f(Z1, Z2) and Z1 ⊥ Z2
t Λ0(t) Λ̂b0(t) Λ̂
u
0(t) Λ̂
w
0,1(t) Λ̂
w
0,2(t) Λ̂
w
0,3(t) Λ̂
w
0,4(t) Λ̂
b
0(t) Λ̂
u
0(t) Λ̂
w
0,1(t) Λ̂
w
0,2(t) Λ̂
w
0,3(t) Λ̂
w
0,4(t)
20 0.04 PBias 58.3% 0.6% 0.6% 0.7% 0.7% 0.7% 58.2% 21.8% 2.5% 1.7% 1.7% 1.7%
ESD 0.89 0.41 0.41 0.40 0.40 0.40 0.89 0.49 0.55 0.52 0.51 0.52
ASEd 0.89 0.46 0.44 0.42 0.41 0.40 0.89 0.55 0.57 0.53 0.52 0.52
ASE 0.44 0.42 0.41 0.40 0.57 0.53 0.52 0.52
sMSE 2.61 0.41 0.41 0.40 0.40 0.40 2.60 1.04 0.56 0.52 0.52 0.52
CPd 15.8% 97.0% 96.6% 95.7% 95.5% 94.9% 16.9% 64.8% 95.7% 95.9% 95.9% 95.7%
CP 96.6% 95.7% 95.5% 94.9% 95.7% 95.9% 95.9% 95.7%
40 0.16 PBias 11.3% 0.7% 0.7% 0.8% 0.8% 0.8% 11.4% 22.9% 2.5% 1.7% 1.7% 1.7%
ESD 1.98 1.42 1.41 1.38 1.37 1.37 2.00 1.70 2.05 1.88 1.88 1.89
ASEd 2.01 1.60 1.52 1.42 1.41 1.38 2.01 1.89 2.07 1.93 1.92 1.91
ASE 1.52 1.42 1.41 1.38 2.07 1.93 1.92 1.91
sMSE 2.71 1.43 1.42 1.38 1.38 1.37 2.74 4.12 2.09 1.90 1.90 1.91
CPd 88.5% 97.1% 96.4% 95.4% 95.5% 95.1% 87.9% 50.3% 94.9% 95.6% 95.4% 95.4%
CP 96.4% 95.4% 95.5% 95.1% 94.9% 95.6% 95.4% 95.4%
60 0.37 PBias -10.2% 0.7% 0.7% 0.8% 0.8% 0.8% -10.0% 24.1% 2.5% 1.6% 1.6% 1.7%
ESD 3.85 2.78 2.75 2.66 2.65 2.65 3.92 3.29 4.35 3.94 3.94 3.95
ASEd 3.83 3.08 2.88 2.70 2.70 2.68 3.83 3.61 4.25 4.02 4.02 4.01
ASE 2.88 2.70 2.70 2.68 4.25 4.02 4.02 4.01
sMSE 5.36 2.79 2.77 2.67 2.67 2.66 5.37 9.43 4.44 3.98 3.98 3.99
CPd 79.5% 97.1% 96.1% 95.8% 95.7% 95.8% 78.0% 28.6% 93.7% 95.8% 95.8% 95.7%
CP 96.1% 95.8% 95.7% 95.8% 93.7% 95.8% 95.8% 95.7%
CAD 1.31 0.50 0.50 0.49 0.48 0.48 1.32 1.76 0.74 0.69 0.68 0.68
(C3) Z1 ∼ Bernoulli(0.5), (C4) Z1 ∼ Bernoulli(0.8),
Z2|Z1=1 ∼ N(0.5, 1.2), Z2|Z1=1 ∼ N(0.5, 1.2),
and Z2|Z1=0 ∼ N(−0.5, 0.8) and Z2|Z1=0 ∼ N(−0.5, 0.8)
t Λ0(t) Λ̂b0(t) Λ̂
u
0(t) Λ̂
w
0,1(t) Λ̂
w
0,2(t) Λ̂
w
0,3(t) Λ̂
w
0,4(t) Λ̂
b
0(t) Λ̂
u
0(t) Λ̂
w
0,1(t) Λ̂
w
0,2(t) Λ̂
w
0,3(t) Λ̂
w
0,4(t)
20 0.04 PBias 57.9% 22.3% 22.3% 22.2% 15.3% 0.6% 57.7% 73.1% 45.7% 12.1% 4.7% 1.2%
ESD 0.89 0.50 0.49 0.48 0.48 0.52 0.90 0.70 0.80 0.65 0.63 0.65
ASEd 0.89 0.56 0.53 0.50 0.49 0.52 0.89 0.77 0.80 0.63 0.62 0.63
ASE 0.53 0.50 0.49 0.52 0.80 0.63 0.62 0.63
sMSE 2.59 1.06 1.06 1.05 0.80 0.52 2.59 3.15 2.08 0.82 0.66 0.65
CPd 17.1% 63.9% 60.6% 55.0% 76.9% 95.0% 17.4% 0.4% 31.9% 91.5% 95.4% 94.2%
CP 60.6% 55.0% 76.9% 95.0% 31.9% 91.5% 95.4% 94.2%
40 0.16 PBias 11.2% 12.2% 12.2% 12.2% 8.3% 1.5% 11.3% 63.8% 36.4% 7.6% 5.4% 2.6%
ESD 2.05 1.58 1.57 1.52 1.49 1.61 2.01 2.20 2.76 2.14 2.11 2.18
ASEd 2.01 1.75 1.66 1.56 1.52 1.62 2.01 2.40 2.68 2.13 2.10 2.13
ASE 1.66 1.56 1.52 1.62 2.68 2.13 2.10 2.13
sMSE 2.75 2.56 2.55 2.51 2.02 1.63 2.74 10.70 6.58 2.48 2.29 2.22
CPd 88.0% 83.4% 81.5% 77.8% 88.4% 95.0% 88.6% 0.1% 41.5% 94.0% 95.3% 94.9%
CP 81.5% 77.8% 88.4% 95.0% 41.5% 94.0% 95.3% 94.9%
60 0.37 PBias -10.3% 3.0% 3.0% 3.0% 1.5% 2.0% -10.2% 54.2% 27.1% 2.5% 4.1% 3.3%
ESD 3.95 2.88 2.85 2.72 2.69 2.80 3.83 4.01 5.47 4.13 4.12 4.26
ASEd 3.81 3.13 2.93 2.75 2.73 2.82 3.82 4.25 5.14 4.13 4.13 4.21
ASE 2.93 2.75 2.72 2.82 5.14 4.13 4.13 4.21
sMSE 5.46 3.09 3.06 2.93 2.75 2.89 5.36 20.24 11.32 4.23 4.39 4.43
CPd 78.0% 95.5% 94.7% 93.9% 94.9% 94.6% 79.1% 0.0% 56.3% 95.2% 95.4% 94.9%
CP 94.7% 93.9% 94.9% 94.6% 56.3% 95.2% 95.4% 94.9%
CAD 1.32 0.87 0.86 0.85 0.68 0.57 1.32 4.63 2.57 0.85 0.80 0.78
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Table S4: Summary statistics of simulation results for the scenario of m = 1, 000,
(A1) Λ∗0(t) = Λ0(t) = (0.01t)
2, and n = 1, 000.
(C1) Z1 ∼ Bernoulli(0.5), Z2 ∼ N(0, 1), (C2) Z1 ∼ Bernoulli(0.8), Z2 ∼ N(0, 1),
and Z1 ⊥ Z2, i.e., f∗(Z1, Z2) = f(Z1, Z2) and Z1 ⊥ Z2
t Λ0(t) Λ̂b0(t) Λ̂
u
0(t) Λ̂
w
0,1(t) Λ̂
w
0,2(t) Λ̂
w
0,3(t) Λ̂
w
0,4(t) Λ̂
b
0(t) Λ̂
u
0(t) Λ̂
w
0,1(t) Λ̂
w
0,2(t) Λ̂
w
0,3(t) Λ̂
w
0,4(t)
20 0.04 PBias 0.2% 0.9% 0.9% 0.8% 0.8% 0.8% 0.1% 22.0% 2.4% 1.6% 1.7% 1.7%
ESD 0.66 0.65 0.65 0.63 0.63 0.63 0.65 0.75 0.73 0.71 0.70 0.70
ASEd 0.65 0.69 0.68 0.67 0.67 0.66 0.65 0.80 0.75 0.73 0.72 0.72
ASE 0.68 0.67 0.67 0.66 0.75 0.73 0.72 0.72
sMSE 0.66 0.65 0.65 0.63 0.63 0.63 0.65 1.19 0.74 0.71 0.71 0.71
CPd 94.1% 95.8% 95.6% 95.4% 95.6% 95.4% 94.5% 85.2% 95.8% 95.7% 95.8% 95.7%
CP 95.6% 95.4% 95.5% 95.4% 95.8% 95.7% 95.8% 95.7%
40 0.16 PBias -1.4% 0.8% 0.8% 0.7% 0.7% 0.7% -1.6% 23.2% 2.4% 1.7% 1.7% 1.8%
ESD 1.87 1.88 1.87 1.79 1.78 1.77 1.91 2.23 2.38 2.26 2.26 2.26
ASEd 1.87 2.00 1.95 1.91 1.90 1.89 1.86 2.35 2.40 2.31 2.30 2.30
ASE 1.95 1.91 1.90 1.89 2.40 2.31 2.30 2.30
sMSE 1.88 1.88 1.87 1.79 1.78 1.78 1.92 4.41 2.41 2.28 2.27 2.28
CPd 93.9% 96.7% 95.9% 96.8% 96.7% 96.7% 94.3% 68.1% 94.7% 95.4% 95.3% 95.3%
CP 95.9% 96.8% 96.7% 96.7% 94.7% 95.4% 95.3% 95.4%
60 0.37 PBias -3.4% 0.9% 0.8% 0.8% 0.8% 0.8% -3.3% 24.2% 2.2% 1.4% 1.4% 1.5%
ESD 4.36 3.64 3.60 3.41 3.40 3.40 4.21 4.32 4.94 4.66 4.65 4.68
ASEd 4.22 3.79 3.66 3.61 3.61 3.59 4.24 4.47 4.86 4.70 4.70 4.69
ASE 3.66 3.61 3.61 3.60 4.86 4.70 4.70 4.69
sMSE 4.53 3.65 3.61 3.42 3.42 3.41 4.37 9.84 5.00 4.69 4.68 4.71
CPd 91.2% 95.9% 95.4% 96.4% 96.4% 96.3% 92.3% 50.6% 94.3% 95.1% 95.0% 94.9%
CP 95.4% 96.4% 96.4% 96.3% 94.3% 95.1% 95.0% 94.9%
CAD 0.74 0.68 0.68 0.65 0.65 0.65 0.73 1.81 0.88 0.83 0.83 0.83
(C3) Z1 ∼ Bernoulli(0.5), (C4) Z1 ∼ Bernoulli(0.8),
Z2|Z1=1 ∼ N(0.5, 1.2), Z2|Z1=1 ∼ N(0.5, 1.2),
and Z2|Z1=0 ∼ N(−0.5, 0.8) and Z2|Z1=0 ∼ N(−0.5, 0.8)
t Λ0(t) Λ̂b0(t) Λ̂
u
0(t) Λ̂
w
0,1(t) Λ̂
w
0,2(t) Λ̂
w
0,3(t) Λ̂
w
0,4(t) Λ̂
b
0(t) Λ̂
u
0(t) Λ̂
w
0,1(t) Λ̂
w
0,2(t) Λ̂
w
0,3(t) Λ̂
w
0,4(t)
20 0.04 PBias 0.3% 22.3% 22.4% 22.3% 15.5% 1.0% 1.0% 73.8% 45.5% 12.7% 5.3% 2.0%
ESD 0.64 0.77 0.77 0.75 0.73 0.73 0.65 0.98 0.97 0.78 0.75 0.77
ASEd 0.65 0.80 0.78 0.78 0.76 0.74 0.65 1.05 1.01 0.82 0.79 0.78
ASE 0.78 0.77 0.75 0.74 1.01 0.81 0.78 0.78
sMSE 0.64 1.22 1.21 1.20 0.98 0.73 0.65 3.25 2.15 0.94 0.78 0.77
CPd 94.8% 85.4% 84.9% 84.2% 91.8% 95.4% 94.9% 8.8% 55.3% 96.2% 96.7% 95.5%
CP 84.9% 84.0% 91.2% 95.2% 55.3% 96.1% 96.6% 95.4%
40 0.16 PBias -1.2% 12.4% 12.4% 12.4% 8.6% 1.9% -0.9% 64.0% 35.9% 7.9% 5.6% 2.9%
ESD 1.87 1.99 1.95 1.87 1.84 1.95 1.88 2.78 3.02 2.38 2.36 2.45
ASEd 1.87 2.18 2.12 2.11 2.08 2.18 1.87 2.95 3.08 2.53 2.51 2.53
ASE 2.12 2.09 2.05 2.15 3.08 2.52 2.49 2.52
sMSE 1.88 2.84 2.82 2.76 2.32 1.97 1.88 10.85 6.61 2.71 2.53 2.50
CPd 93.9% 90.5% 89.7% 90.4% 95.0% 97.3% 94.3% 2.1% 54.8% 95.8% 96.7% 96.2%
CP 89.7% 89.9% 94.8% 97.1% 54.8% 95.8% 96.5% 96.1%
60 0.37 PBias -2.7% 3.1% 3.1% 3.1% 1.6% 2.1% -2.8% 54.3% 26.5% 2.7% 4.3% 3.5%
ESD 4.22 3.58 3.50 3.31 3.29 3.48 4.20 5.11 5.91 4.61 4.65 4.84
ASEd 4.25 3.86 3.72 3.74 3.73 3.99 4.25 5.31 5.87 4.86 4.93 5.04
ASE 3.72 3.70 3.68 3.98 5.87 4.84 4.92 5.05
sMSE 4.34 3.75 3.68 3.49 3.35 3.56 4.32 20.52 11.36 4.71 4.91 5.01
CPd 93.0% 96.8% 96.7% 97.1% 97.3% 97.5% 92.4% 1.1% 68.2% 97.1% 97.0% 97.0%
CP 96.7% 97.0% 97.2% 97.4% 68.2% 97.0% 97.0% 97.1%
CAD 0.73 0.97 0.96 0.94 0.80 0.71 0.72 4.64 2.54 0.94 0.90 0.89
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Table S5: Summary statistics of simulation results for the scenario of m = 1, 000,
(A2) Λ0(t) = (0.01t)
2 and Λ∗0(t) = (0.01t)
1.5, and n = 1, 000.
(C1) Z1 ∼ Bernoulli(0.5), Z2 ∼ N(0, 1), (C2) Z1 ∼ Bernoulli(0.8), Z2 ∼ N(0, 1),
and Z1 ⊥ Z2, i.e., f∗(Z1, Z2) = f(Z1, Z2) and Z1 ⊥ Z2
t Λ0(t) Λ̂b0(t) Λ̂
u
0(t) Λ̂
w
0,1(t) Λ̂
w
0,2(t) Λ̂
w
0,3(t) Λ̂
w
0,4(t) Λ̂
b
0(t) Λ̂
u
0(t) Λ̂
w
0,1(t) Λ̂
w
0,2(t) Λ̂
w
0,3(t) Λ̂
w
0,4(t)
20 0.04 PBias 121.0% 2.1% 2.0% 1.9% 1.9% 1.9% 120.0% 21.8% 2.1% 1.5% 1.5% 1.5%
ESD 1.07 0.65 0.64 0.63 0.62 0.62 1.11 0.73 0.70 0.67 0.67 0.67
ASEd 1.08 0.66 0.65 0.64 0.64 0.63 1.08 0.76 0.70 0.67 0.67 0.67
ASE 0.65 0.64 0.64 0.63 0.70 0.67 0.67 0.67
sMSE 5.20 0.65 0.65 0.63 0.63 0.63 5.16 1.17 0.71 0.68 0.67 0.67
CPd 0.1% 95.6% 95.3% 95.9% 95.6% 95.5% 0.0% 83.3% 94.6% 94.6% 94.7% 94.5%
CP 95.3% 95.9% 95.5% 95.5% 94.6% 94.6% 94.7% 94.5%
40 0.16 PBias 55.8% 1.5% 1.5% 1.4% 1.4% 1.4% 55.4% 23.1% 2.2% 1.6% 1.6% 1.6%
ESD 2.41 1.79 1.77 1.68 1.68 1.67 2.50 2.05 2.16 2.03 2.02 2.02
ASEd 2.45 1.88 1.82 1.77 1.77 1.75 2.45 2.19 2.17 2.07 2.07 2.06
ASE 1.82 1.77 1.77 1.75 2.17 2.07 2.07 2.06
sMSE 9.46 1.81 1.78 1.70 1.70 1.69 9.43 4.31 2.19 2.05 2.04 2.04
CPd 1.6% 95.7% 95.9% 96.1% 96.3% 96.0% 1.9% 63.4% 95.0% 95.5% 95.4% 95.4%
CP 95.9% 96.1% 96.3% 96.0% 95.0% 95.4% 95.4% 95.4%
60 0.37 PBias 25.8% 1.3% 1.3% 1.3% 1.3% 1.3% 25.2% 24.1% 2.1% 1.4% 1.4% 1.5%
ESD 4.93 3.34 3.27 3.06 3.06 3.06 4.74 3.98 4.46 4.14 4.14 4.15
ASEd 4.80 3.53 3.39 3.33 3.33 3.32 4.77 4.15 4.35 4.19 4.19 4.18
ASE 3.39 3.33 3.33 3.32 4.35 4.19 4.19 4.18
sMSE 10.64 3.38 3.31 3.09 3.09 3.09 10.35 9.69 4.52 4.18 4.17 4.18
CPd 51.3% 96.0% 95.8% 97.3% 97.3% 97.3% 53.9% 42.6% 94.2% 95.0% 95.1% 94.9%
CP 95.8% 97.3% 97.3% 97.3% 94.2% 95.0% 95.1% 94.9%
CAD 3.93 0.65 0.64 0.61 0.61 0.61 3.90 1.79 0.79 0.74 0.74 0.74
(C3) Z1 ∼ Bernoulli(0.5), (C4) Z1 ∼ Bernoulli(0.8),
Z2|Z1=1 ∼ N(0.5, 1.2), Z2|Z1=1 ∼ N(0.5, 1.2),
and Z2|Z1=0 ∼ N(−0.5, 0.8) and Z2|Z1=0 ∼ N(−0.5, 0.8)
t Λ0(t) Λ̂b0(t) Λ̂
u
0(t) Λ̂
w
0,1(t) Λ̂
w
0,2(t) Λ̂
w
0,3(t) Λ̂
w
0,4(t) Λ̂
b
0(t) Λ̂
u
0(t) Λ̂
w
0,1(t) Λ̂
w
0,2(t) Λ̂
w
0,3(t) Λ̂
w
0,4(t)
20 0.04 PBias 121.1% 22.5% 22.4% 22.4% 15.6% 1.0% 120.9% 73.2% 45.0% 11.9% 4.6% 1.1%
ESD 1.09 0.72 0.71 0.69 0.67 0.66 1.09 0.91 0.88 0.70 0.67 0.68
ASEd 1.08 0.76 0.74 0.74 0.72 0.69 1.08 0.98 0.93 0.74 0.72 0.71
ASE 0.74 0.73 0.71 0.68 0.93 0.74 0.71 0.70
sMSE 5.20 1.19 1.18 1.17 0.94 0.66 5.19 3.21 2.09 0.86 0.70 0.68
CPd 0.1% 83.0% 82.3% 82.0% 91.4% 95.9% 0.0% 5.2% 48.7% 94.9% 96.4% 96.0%
CP 82.3% 81.6% 91.0% 95.6% 48.7% 94.8% 96.4% 95.9%
40 0.16 PBias 55.4% 12.2% 12.2% 12.2% 8.4% 1.6% 55.1% 64.3% 36.1% 7.8% 5.5% 2.7%
ESD 2.42 1.86 1.82 1.72 1.70 1.78 2.49 2.53 2.69 2.10 2.09 2.14
ASEd 2.45 2.03 1.96 1.95 1.93 2.00 2.45 2.75 2.78 2.27 2.26 2.27
ASE 1.96 1.93 1.90 1.98 2.78 2.26 2.24 2.25
sMSE 9.40 2.73 2.70 2.64 2.18 1.80 9.37 10.85 6.50 2.46 2.27 2.18
CPd 1.7% 88.9% 88.2% 88.1% 94.0% 97.2% 1.8% 0.9% 43.7% 95.9% 96.5% 96.4%
CP 88.2% 87.8% 93.5% 97.1% 43.7% 95.9% 96.3% 96.4%
60 0.37 PBias 24.7% 2.9% 2.9% 2.9% 1.5% 1.9% 25.1% 54.6% 26.7% 2.6% 4.2% 3.4%
ESD 4.68 3.37 3.26 3.06 3.06 3.23 4.78 4.70 5.24 4.01 4.07 4.18
ASEd 4.75 3.58 3.42 3.45 3.45 3.70 4.77 4.94 5.27 4.35 4.43 4.53
ASE 3.42 3.41 3.40 3.68 5.27 4.33 4.42 4.54
sMSE 10.19 3.53 3.43 3.24 3.11 3.30 10.35 20.51 11.08 4.12 4.36 4.36
CPd 54.4% 96.3% 96.2% 97.1% 97.5% 97.8% 53.5% 0.5% 58.9% 96.8% 96.6% 96.6%
CP 96.2% 96.9% 97.2% 97.8% 58.9% 96.6% 96.5% 96.6%
CAD 3.89 0.93 0.92 0.90 0.75 0.65 3.89 4.66 2.54 0.85 0.81 0.78
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Table S6: Summary statistics of simulation results for the scenario of m = 1, 000,
(A3) Λ0(t) = (0.01t)
2 and Λ∗0(t) = (0.008t)
2, and n = 1, 000.
(C1) Z1 ∼ Bernoulli(0.5), Z2 ∼ N(0, 1), (C2) Z1 ∼ Bernoulli(0.8), Z2 ∼ N(0, 1),
and Z1 ⊥ Z2, i.e., f∗(Z1, Z2) = f(Z1, Z2) and Z1 ⊥ Z2
t Λ0(t) Λ̂b0(t) Λ̂
u
0(t) Λ̂
w
0,1(t) Λ̂
w
0,2(t) Λ̂
w
0,3(t) Λ̂
w
0,4(t) Λ̂
b
0(t) Λ̂
u
0(t) Λ̂
w
0,1(t) Λ̂
w
0,2(t) Λ̂
w
0,3(t) Λ̂
w
0,4(t)
20 0.04 PBias -35.9% 1.6% 1.5% 1.5% 1.6% 1.5% -36.3% 21.2% 1.8% 1.1% 1.2% 1.2%
ESD 0.52 0.71 0.71 0.70 0.70 0.70 0.50 0.80 0.79 0.77 0.76 0.76
ASEd 0.50 0.74 0.73 0.72 0.72 0.71 0.50 0.85 0.82 0.80 0.80 0.79
ASE 0.73 0.72 0.72 0.71 0.82 0.80 0.80 0.79
sMSE 1.60 0.72 0.71 0.70 0.70 0.70 1.60 1.20 0.79 0.77 0.77 0.77
CPd 20.9% 95.1% 94.9% 95.0% 95.1% 95.0% 19.5% 88.6% 95.6% 95.3% 95.4% 95.3%
CP 94.9% 95.0% 95.1% 95.0% 95.6% 95.3% 95.3% 95.3%
40 0.16 PBias -36.7% 1.4% 1.3% 1.3% 1.3% 1.3% -37.0% 23.0% 2.3% 1.6% 1.7% 1.7%
ESD 1.49 2.10 2.09 2.03 2.02 2.02 1.44 2.41 2.62 2.49 2.49 2.49
ASEd 1.45 2.21 2.16 2.12 2.12 2.10 1.44 2.59 2.72 2.64 2.63 2.62
ASE 2.16 2.12 2.12 2.10 2.72 2.64 2.63 2.62
sMSE 6.20 2.11 2.10 2.04 2.03 2.03 6.24 4.47 2.64 2.51 2.50 2.50
CPd 4.1% 96.4% 95.8% 95.8% 96.3% 96.0% 3.2% 76.8% 95.5% 96.0% 96.0% 96.0%
CP 95.8% 95.8% 96.4% 96.0% 95.5% 96.0% 96.0% 96.0%
60 0.37 PBias -37.7% 1.3% 1.2% 1.2% 1.2% 1.2% -37.9% 24.4% 2.4% 1.7% 1.8% 1.8%
ESD 3.23 4.01 3.98 3.80 3.79 3.80 3.17 4.67 5.47 5.18 5.18 5.18
ASEd 3.21 4.20 4.08 4.04 4.03 4.02 3.20 4.94 5.56 5.42 5.42 5.41
ASE 4.08 4.04 4.03 4.03 5.56 5.42 5.42 5.42
sMSE 14.16 4.04 4.00 3.82 3.82 3.82 14.24 10.06 5.54 5.22 5.22 5.22
CPd 3.9% 96.8% 96.3% 96.6% 96.6% 96.5% 2.9% 60.5% 94.7% 95.9% 95.9% 95.9%
CP 96.3% 96.6% 96.6% 96.5% 94.7% 95.9% 95.9% 95.9%
CAD 2.80 0.76 0.76 0.73 0.73 0.73 2.82 1.82 0.96 0.91 0.91 0.91
(C3) Z1 ∼ Bernoulli(0.5), (C4) Z1 ∼ Bernoulli(0.8),
Z2|Z1=1 ∼ N(0.5, 1.2), Z2|Z1=1 ∼ N(0.5, 1.2),
and Z2|Z1=0 ∼ N(−0.5, 0.8) and Z2|Z1=0 ∼ N(−0.5, 0.8)
t Λ0(t) Λ̂b0(t) Λ̂
u
0(t) Λ̂
w
0,1(t) Λ̂
w
0,2(t) Λ̂
w
0,3(t) Λ̂
w
0,4(t) Λ̂
b
0(t) Λ̂
u
0(t) Λ̂
w
0,1(t) Λ̂
w
0,2(t) Λ̂
w
0,3(t) Λ̂
w
0,4(t)
20 0.04 PBias -35.6% 22.3% 22.3% 22.1% 15.2% 0.8% -35.6% 73.3% 45.4% 12.4% 5.0% 1.5%
ESD 0.52 0.80 0.79 0.77 0.75 0.76 0.51 1.08 1.10 0.90 0.87 0.87
ASEd 0.51 0.86 0.84 0.84 0.82 0.81 0.51 1.13 1.12 0.91 0.89 0.88
ASE 0.84 0.83 0.81 0.81 1.12 0.91 0.88 0.88
sMSE 1.58 1.23 1.23 1.21 0.98 0.76 1.58 3.26 2.21 1.04 0.90 0.87
CPd 21.2% 87.8% 87.2% 87.8% 94.3% 96.8% 21.2% 15.5% 67.3% 95.2% 95.8% 95.5%
CP 87.2% 87.7% 94.0% 96.5% 67.3% 95.2% 95.8% 95.4%
40 0.16 PBias -36.6% 12.6% 12.6% 12.5% 8.6% 2.0% -36.6% 64.0% 36.1% 7.9% 5.6% 2.8%
ESD 1.43 2.21 2.18 2.09 2.05 2.18 1.43 3.13 3.49 2.78 2.76 2.80
ASEd 1.45 2.41 2.35 2.34 2.30 2.42 1.45 3.26 3.50 2.89 2.86 2.89
ASE 2.35 2.32 2.28 2.40 3.50 2.89 2.85 2.88
sMSE 6.17 3.03 3.00 2.92 2.49 2.21 6.17 10.95 6.87 3.07 2.91 2.83
CPd 3.7% 91.6% 91.0% 91.9% 95.8% 97.4% 3.5% 5.4% 67.4% 96.7% 96.2% 95.9%
CP 91.0% 91.5% 95.6% 97.2% 67.4% 96.6% 96.1% 95.8%
60 0.37 PBias -37.4% 3.5% 3.4% 3.4% 1.9% 2.4% -37.6% 54.4% 26.8% 2.8% 4.4% 3.5%
ESD 3.23 3.98 3.90 3.68 3.66 3.87 3.14 5.67 6.77 5.35 5.39 5.50
ASEd 3.22 4.27 4.15 4.17 4.14 4.42 3.21 5.87 6.72 5.57 5.64 5.76
ASE 4.15 4.13 4.10 4.41 6.72 5.55 5.63 5.77
sMSE 14.08 4.18 4.10 3.88 3.73 3.97 14.10 20.69 11.91 5.44 5.62 5.64
CPd 3.6% 96.3% 96.2% 97.4% 97.2% 97.4% 3.2% 3.7% 76.6% 95.9% 95.8% 96.2%
CP 96.2% 97.3% 96.9% 97.3% 76.6% 95.9% 95.8% 96.2%
CAD 2.78 1.03 1.02 0.99 0.85 0.78 2.79 4.64 2.58 1.05 1.01 1.00
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Table S7: Summary statistics of simulation results for the scenario of m = 1, 000,
(A4) Λ0(t) = (0.01t)
2 and Λ∗0(t) = (0.008t)
1.5, and n = 1, 000.
(C1) Z1 ∼ Bernoulli(0.5), Z2 ∼ N(0, 1), (C2) Z1 ∼ Bernoulli(0.8), Z2 ∼ N(0, 1),
and Z1 ⊥ Z2, i.e., f∗(Z1, Z2) = f(Z1, Z2) and Z1 ⊥ Z2
t Λ0(t) Λ̂b0(t) Λ̂
u
0(t) Λ̂
w
0,1(t) Λ̂
w
0,2(t) Λ̂
w
0,3(t) Λ̂
w
0,4(t) Λ̂
b
0(t) Λ̂
u
0(t) Λ̂
w
0,1(t) Λ̂
w
0,2(t) Λ̂
w
0,3(t) Λ̂
w
0,4(t)
20 0.04 PBias 57.7% 0.7% 0.6% 0.7% 0.7% 0.7% 57.3% 21.4% 1.9% 1.4% 1.5% 1.5%
ESD 0.88 0.66 0.65 0.64 0.64 0.64 0.89 0.75 0.73 0.70 0.69 0.70
ASEd 0.88 0.68 0.67 0.66 0.66 0.65 0.88 0.78 0.74 0.71 0.71 0.71
ASE 0.67 0.66 0.66 0.65 0.74 0.71 0.71 0.71
sMSE 2.58 0.66 0.65 0.64 0.64 0.64 2.57 1.17 0.73 0.70 0.70 0.70
CPd 17.4% 95.3% 95.1% 95.4% 95.5% 95.4% 18.2% 85.4% 94.8% 94.7% 94.5% 94.2%
CP 95.1% 95.4% 95.5% 95.4% 94.8% 94.7% 94.5% 94.2%
40 0.16 PBias 11.5% 0.7% 0.7% 0.8% 0.8% 0.8% 11.1% 22.7% 2.0% 1.5% 1.6% 1.6%
ESD 2.03 1.83 1.81 1.75 1.75 1.74 2.02 2.19 2.33 2.19 2.19 2.21
ASEd 2.01 1.97 1.91 1.87 1.87 1.85 2.01 2.31 2.34 2.25 2.24 2.23
ASE 1.91 1.87 1.87 1.85 2.34 2.25 2.24 2.23
sMSE 2.77 1.83 1.82 1.75 1.75 1.75 2.72 4.31 2.36 2.20 2.20 2.22
CPd 87.9% 96.4% 95.9% 96.4% 96.1% 95.8% 88.0% 66.5% 95.6% 96.0% 96.0% 95.8%
CP 95.9% 96.4% 96.1% 95.8% 95.6% 96.0% 96.1% 95.8%
60 0.37 PBias -10.0% 0.8% 0.8% 0.8% 0.9% 0.9% -10.3% 24.1% 2.1% 1.7% 1.7% 1.7%
ESD 3.85 3.46 3.40 3.23 3.23 3.22 3.89 4.21 4.84 4.50 4.50 4.54
ASEd 3.83 3.73 3.59 3.54 3.54 3.53 3.82 4.39 4.74 4.59 4.59 4.58
ASE 3.59 3.54 3.54 3.53 4.74 4.59 4.59 4.58
sMSE 5.32 3.47 3.41 3.24 3.24 3.24 5.41 9.78 4.90 4.54 4.54 4.59
CPd 80.8% 96.7% 96.0% 96.7% 96.7% 96.7% 78.2% 48.5% 94.8% 96.0% 96.0% 95.5%
CP 96.0% 96.7% 96.7% 96.7% 94.8% 96.0% 96.0% 95.5%
CAD 1.32 0.67 0.66 0.64 0.64 0.64 1.31 1.78 0.87 0.82 0.82 0.82
(C3) Z1 ∼ Bernoulli(0.5), (C4) Z1 ∼ Bernoulli(0.8),
Z2|Z1=1 ∼ N(0.5, 1.2), Z2|Z1=1 ∼ N(0.5, 1.2),
and Z2|Z1=0 ∼ N(−0.5, 0.8) and Z2|Z1=0 ∼ N(−0.5, 0.8)
t Λ0(t) Λ̂b0(t) Λ̂
u
0(t) Λ̂
w
0,1(t) Λ̂
w
0,2(t) Λ̂
w
0,3(t) Λ̂
w
0,4(t) Λ̂
b
0(t) Λ̂
u
0(t) Λ̂
w
0,1(t) Λ̂
w
0,2(t) Λ̂
w
0,3(t) Λ̂
w
0,4(t)
20 0.04 PBias 57.9% 21.9% 21.9% 21.6% 14.8% 0.2% 57.2% 73.2% 44.8% 11.9% 4.5% 1.0%
ESD 0.86 0.74 0.74 0.72 0.70 0.69 0.86 0.98 0.96 0.78 0.74 0.75
ASEd 0.89 0.79 0.77 0.76 0.74 0.73 0.88 1.03 0.98 0.80 0.77 0.76
ASE 0.77 0.76 0.74 0.72 0.98 0.79 0.76 0.76
sMSE 2.58 1.18 1.18 1.16 0.93 0.69 2.55 3.23 2.12 0.92 0.77 0.75
CPd 15.7% 86.1% 85.1% 85.1% 93.4% 95.3% 16.7% 8.2% 56.2% 94.8% 96.3% 95.2%
CP 85.1% 84.9% 93.0% 94.9% 56.2% 94.5% 96.1% 95.1%
40 0.16 PBias 11.2% 12.1% 12.0% 11.8% 8.0% 1.2% 11.2% 63.7% 35.4% 7.3% 5.0% 2.2%
ESD 1.94 1.95 1.91 1.83 1.80 1.90 1.96 2.72 2.93 2.30 2.27 2.32
ASEd 2.01 2.15 2.08 2.07 2.04 2.13 2.01 2.90 3.00 2.46 2.44 2.46
ASE 2.08 2.05 2.01 2.10 3.00 2.45 2.42 2.44
sMSE 2.67 2.78 2.74 2.66 2.23 1.91 2.68 10.80 6.50 2.59 2.41 2.35
CPd 89.3% 89.5% 89.3% 90.5% 94.8% 97.1% 89.1% 1.7% 55.4% 96.2% 96.4% 96.0%
CP 89.3% 90.3% 94.6% 96.9% 55.4% 96.1% 96.3% 95.9%
60 0.37 PBias -10.2% 3.0% 2.9% 2.7% 1.3% 1.7% -10.2% 54.2% 26.2% 2.3% 3.9% 3.0%
ESD 3.77 3.46 3.36 3.19 3.18 3.38 3.84 4.98 5.71 4.42 4.46 4.58
ASEd 3.82 3.79 3.65 3.67 3.66 3.91 3.82 5.22 5.72 4.72 4.80 4.90
ASE 3.65 3.62 3.61 3.90 5.72 4.70 4.79 4.91
sMSE 5.31 3.63 3.53 3.34 3.22 3.44 5.36 20.45 11.15 4.50 4.67 4.71
CPd 79.7% 96.7% 96.7% 97.2% 97.4% 97.5% 79.5% 1.5% 67.0% 96.0% 96.5% 96.2%
CP 96.7% 97.1% 97.2% 97.5% 67.0% 96.0% 96.4% 96.3%
CAD 1.31 0.94 0.93 0.90 0.76 0.68 1.30 4.63 2.52 0.89 0.85 0.84
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Table S8: Summary statistics of simulation results for the scenario of m = 200, (A1)
Λ∗0(t) = Λ0(t) = (0.01t)
2, and n = 1, 000.
(C1) Z1 ∼ Bernoulli(0.5), Z2 ∼ N(0, 1), (C2) Z1 ∼ Bernoulli(0.8), Z2 ∼ N(0, 1),
and Z1 ⊥ Z2, i.e., f∗(Z1, Z2) = f(Z1, Z2) and Z1 ⊥ Z2
t Λ0(t) Λ̂b0(t) Λ̂
u
0(t) Λ̂
w
0,1(t) Λ̂
w
0,2(t) Λ̂
w
0,3(t) Λ̂
w
0,4(t) Λ̂
b
0(t) Λ̂
u
0(t) Λ̂
w
0,1(t) Λ̂
w
0,2(t) Λ̂
w
0,3(t) Λ̂
w
0,4(t)
20 0.04 PBias 0.5% 1.9% 1.9% 1.7% 1.8% 1.8% 0.6% 23.4% 3.4% 2.7% 3.0% 3.0%
ESD 0.64 1.21 1.21 1.19 1.18 1.18 0.64 1.36 1.19 1.16 1.15 1.15
ASEd 0.65 1.23 1.22 1.23 1.23 1.23 0.65 1.38 1.21 1.21 1.21 1.21
ASE 1.22 1.23 1.23 1.23 1.21 1.21 1.21 1.21
sMSE 0.64 1.22 1.22 1.19 1.18 1.18 0.64 1.68 1.20 1.16 1.16 1.16
CPd 94.7% 94.1% 93.9% 94.3% 94.4% 94.5% 94.5% 94.9% 95.0% 95.5% 95.3% 95.4%
CP 93.9% 94.3% 94.4% 94.4% 95.0% 95.5% 95.3% 95.4%
40 0.16 PBias -0.6% 1.8% 1.8% 1.6% 1.7% 1.8% -0.9% 23.9% 2.7% 2.2% 2.4% 2.4%
ESD 1.88 3.03 3.00 2.82 2.82 2.81 1.87 3.44 3.14 2.99 2.98 2.98
ASEd 1.87 3.09 3.07 3.13 3.14 3.13 1.87 3.57 3.27 3.29 3.29 3.28
ASE 3.07 3.13 3.14 3.14 3.27 3.29 3.29 3.28
sMSE 1.88 3.04 3.01 2.84 2.83 2.82 1.88 5.21 3.17 3.01 3.01 3.00
CPd 94.5% 95.0% 94.8% 96.5% 96.5% 96.6% 94.7% 88.2% 95.2% 96.9% 97.1% 97.1%
CP 94.8% 96.4% 96.4% 96.5% 95.2% 96.9% 97.1% 97.1%
60 0.37 PBias -2.9% 1.6% 1.6% 1.5% 1.5% 1.6% -2.6% 25.4% 2.9% 2.4% 2.5% 2.5%
ESD 4.32 5.73 5.63 5.21 5.20 5.20 4.23 6.62 6.20 5.78 5.79 5.78
ASEd 4.24 5.71 5.68 5.88 5.88 5.88 4.25 6.78 6.42 6.50 6.50 6.49
ASE 5.68 5.88 5.88 5.90 6.42 6.50 6.50 6.50
sMSE 4.45 5.76 5.66 5.24 5.24 5.23 4.34 11.40 6.29 5.85 5.86 5.85
CPd 92.7% 94.9% 95.3% 97.2% 97.4% 97.4% 93.1% 79.5% 95.5% 97.2% 97.3% 97.2%
CP 95.3% 97.2% 97.4% 97.4% 95.5% 97.2% 97.2% 97.3%
CAD 0.72 1.12 1.11 1.05 1.05 1.05 0.73 2.03 1.16 1.11 1.11 1.11
(C3) Z1 ∼ Bernoulli(0.5), (C4) Z1 ∼ Bernoulli(0.8),
Z2|Z1=1 ∼ N(0.5, 1.2), Z2|Z1=1 ∼ N(0.5, 1.2),
and Z2|Z1=0 ∼ N(−0.5, 0.8) and Z2|Z1=0 ∼ N(−0.5, 0.8)
t Λ0(t) Λ̂b0(t) Λ̂
u
0(t) Λ̂
w
0,1(t) Λ̂
w
0,2(t) Λ̂
w
0,3(t) Λ̂
w
0,4(t) Λ̂
b
0(t) Λ̂
u
0(t) Λ̂
w
0,1(t) Λ̂
w
0,2(t) Λ̂
w
0,3(t) Λ̂
w
0,4(t)
20 0.04 PBias 0.4% 22.3% 22.3% 22.0% 15.3% 1.1% 0.0% 75.0% 46.5% 13.1% 6.4% 2.8%
ESD 0.65 1.38 1.37 1.33 1.27 1.18 0.64 1.75 1.55 1.21 1.16 1.14
ASEd 0.65 1.37 1.37 1.40 1.36 1.26 0.64 1.74 1.54 1.28 1.22 1.18
ASE 1.37 1.39 1.34 1.24 1.54 1.27 1.20 1.17
sMSE 0.65 1.67 1.66 1.62 1.42 1.18 0.64 3.61 2.49 1.33 1.19 1.15
CPd 94.2% 94.3% 94.7% 96.1% 97.1% 94.6% 94.7% 62.6% 85.8% 97.0% 96.2% 94.9%
CP 94.7% 96.0% 96.8% 94.4% 85.8% 96.9% 95.9% 94.6%
40 0.16 PBias -1.2% 12.4% 12.4% 12.2% 8.6% 1.9% -1.1% 64.8% 36.5% 8.3% 6.1% 3.4%
ESD 1.85 3.31 3.21 2.99 2.94 3.03 1.89 4.37 4.08 3.13 3.14 3.18
ASEd 1.87 3.32 3.30 3.47 3.45 3.54 1.87 4.44 4.12 3.57 3.56 3.55
ASE 3.30 3.41 3.37 3.47 4.12 3.54 3.51 3.51
sMSE 1.86 3.88 3.80 3.60 3.26 3.05 1.90 11.49 7.24 3.41 3.30 3.23
CPd 94.3% 94.3% 94.8% 97.4% 98.0% 97.3% 94.3% 29.3% 78.6% 97.7% 97.8% 97.0%
CP 94.8% 97.2% 97.8% 97.1% 78.6% 97.5% 97.4% 96.8%
60 0.37 PBias -3.2% 3.3% 3.3% 3.2% 2.0% 2.3% -3.2% 55.0% 27.0% 3.3% 4.6% 3.9%
ESD 4.31 5.72 5.45 4.98 5.03 5.45 4.26 8.16 7.77 5.98 6.11 6.29
ASEd 4.22 5.79 5.76 6.18 6.20 6.79 4.24 8.11 7.74 6.76 7.00 7.19
ASE 5.76 6.05 6.06 6.76 7.74 6.69 6.97 7.22
sMSE 4.47 5.84 5.58 5.12 5.08 5.51 4.41 21.73 12.58 6.10 6.34 6.45
CPd 91.9% 95.2% 96.5% 98.2% 98.2% 98.1% 92.7% 25.2% 82.4% 97.1% 97.6% 97.7%
CP 96.5% 98.1% 98.0% 98.1% 82.4% 96.9% 97.5% 97.7%
CAD 0.73 1.32 1.29 1.23 1.13 1.09 0.73 4.72 2.67 1.21 1.19 1.18
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Table S9: Summary statistics of simulation results for the scenario of m = 200, (A2)
Λ0(t) = (0.01t)
2 and Λ∗0(t) = (0.01t)
1.5, and n = 1, 000.
(C1) Z1 ∼ Bernoulli(0.5), Z2 ∼ N(0, 1), (C2) Z1 ∼ Bernoulli(0.8), Z2 ∼ N(0, 1),
and Z1 ⊥ Z2, i.e., f∗(Z1, Z2) = f(Z1, Z2) and Z1 ⊥ Z2
t Λ0(t) Λ̂b0(t) Λ̂
u
0(t) Λ̂
w
0,1(t) Λ̂
w
0,2(t) Λ̂
w
0,3(t) Λ̂
w
0,4(t) Λ̂
b
0(t) Λ̂
u
0(t) Λ̂
w
0,1(t) Λ̂
w
0,2(t) Λ̂
w
0,3(t) Λ̂
w
0,4(t)
20 0.04 PBias 120.5% 1.2% 1.2% 0.9% 1.0% 0.9% 121.0% 22.6% 2.6% 2.0% 2.1% 2.2%
ESD 1.07 1.24 1.23 1.20 1.20 1.20 1.12 1.35 1.17 1.14 1.14 1.14
ASEd 1.08 1.20 1.20 1.20 1.21 1.21 1.08 1.35 1.17 1.17 1.17 1.17
ASE 1.20 1.20 1.21 1.21 1.17 1.17 1.17 1.17
sMSE 5.18 1.24 1.24 1.20 1.20 1.20 5.21 1.65 1.18 1.15 1.15 1.15
CPd 0.0% 93.5% 93.5% 93.6% 93.5% 93.5% 0.1% 94.5% 94.6% 94.5% 94.8% 94.8%
CP 93.5% 93.6% 93.5% 93.5% 94.6% 94.5% 94.8% 94.9%
40 0.16 PBias 55.6% 1.7% 1.7% 1.4% 1.5% 1.5% 56.1% 23.9% 2.6% 2.1% 2.2% 2.3%
ESD 2.46 2.95 2.92 2.77 2.75 2.75 2.52 3.35 3.02 2.88 2.87 2.88
ASEd 2.45 2.99 2.98 3.04 3.04 3.04 2.46 3.46 3.11 3.13 3.13 3.12
ASE 2.98 3.04 3.04 3.04 3.11 3.13 3.13 3.12
sMSE 9.44 2.96 2.94 2.77 2.76 2.76 9.54 5.15 3.05 2.90 2.90 2.91
CPd 2.0% 95.3% 95.3% 96.3% 96.1% 96.1% 2.3% 87.4% 95.2% 96.5% 96.5% 96.6%
CP 95.3% 96.3% 96.1% 96.2% 95.2% 96.5% 96.7% 96.7%
60 0.37 PBias 25.2% 1.9% 1.9% 1.7% 1.7% 1.7% 25.7% 25.1% 2.6% 2.1% 2.2% 2.3%
ESD 4.83 5.48 5.40 4.98 4.97 4.97 5.01 6.39 5.89 5.48 5.48 5.51
ASEd 4.78 5.54 5.51 5.71 5.71 5.71 4.79 6.55 6.03 6.13 6.13 6.11
ASE 5.51 5.71 5.71 5.73 6.03 6.13 6.13 6.12
sMSE 10.42 5.52 5.44 5.02 5.01 5.01 10.64 11.19 5.97 5.54 5.53 5.57
CPd 52.3% 95.2% 95.3% 97.5% 97.6% 97.3% 50.9% 77.0% 95.5% 97.1% 97.0% 96.8%
CP 95.3% 97.5% 97.6% 97.4% 95.5% 97.1% 97.0% 96.8%
CAD 3.90 1.09 1.08 1.02 1.01 1.01 3.93 2.00 1.13 1.07 1.06 1.07
(C3) Z1 ∼ Bernoulli(0.5), (C4) Z1 ∼ Bernoulli(0.8),
Z2|Z1=1 ∼ N(0.5, 1.2), Z2|Z1=1 ∼ N(0.5, 1.2),
and Z2|Z1=0 ∼ N(−0.5, 0.8) and Z2|Z1=0 ∼ N(−0.5, 0.8)
t Λ0(t) Λ̂b0(t) Λ̂
u
0(t) Λ̂
w
0,1(t) Λ̂
w
0,2(t) Λ̂
w
0,3(t) Λ̂
w
0,4(t) Λ̂
b
0(t) Λ̂
u
0(t) Λ̂
w
0,1(t) Λ̂
w
0,2(t) Λ̂
w
0,3(t) Λ̂
w
0,4(t)
20 0.04 PBias 120.8% 22.9% 22.8% 22.3% 15.7% 1.5% 120.1% 73.0% 44.1% 11.7% 4.7% 1.2%
ESD 1.08 1.35 1.33 1.29 1.23 1.15 1.05 1.63 1.41 1.09 1.04 1.01
ASEd 1.08 1.35 1.35 1.38 1.34 1.24 1.08 1.69 1.47 1.22 1.16 1.12
ASE 1.35 1.37 1.32 1.21 1.47 1.21 1.14 1.11
sMSE 5.19 1.66 1.64 1.60 1.40 1.15 5.15 3.47 2.33 1.20 1.06 1.01
CPd 0.0% 94.4% 94.6% 96.2% 97.2% 95.4% 0.0% 61.5% 86.4% 97.5% 96.6% 95.4%
CP 94.6% 95.8% 96.9% 95.3% 86.4% 97.5% 96.4% 95.2%
40 0.16 PBias 55.7% 12.6% 12.4% 12.2% 8.6% 1.9% 55.4% 63.5% 34.7% 7.3% 5.0% 2.2%
ESD 2.45 3.08 2.98 2.82 2.77 2.87 2.35 4.15 3.71 2.89 2.90 2.92
ASEd 2.45 3.22 3.20 3.37 3.36 3.44 2.45 4.27 3.86 3.36 3.36 3.34
ASE 3.20 3.31 3.27 3.36 3.86 3.33 3.30 3.29
sMSE 9.46 3.70 3.61 3.45 3.11 2.89 9.38 11.21 6.79 3.13 3.01 2.94
CPd 1.8% 95.4% 95.6% 97.6% 97.9% 97.7% 1.9% 26.8% 76.7% 98.7% 98.2% 97.4%
CP 95.6% 97.4% 97.9% 97.3% 76.7% 98.6% 98.0% 97.1%
60 0.37 PBias 25.6% 3.8% 3.6% 3.4% 2.2% 2.6% 25.2% 54.1% 25.5% 2.3% 3.7% 2.9%
ESD 4.87 5.33 5.10 4.68 4.73 5.15 4.80 7.58 6.84 5.22 5.38 5.52
ASEd 4.78 5.61 5.58 6.01 6.04 6.62 4.78 7.82 7.20 6.35 6.60 6.79
ASE 5.58 5.87 5.89 6.59 7.20 6.27 6.57 6.81
sMSE 10.55 5.51 5.27 4.85 4.80 5.24 10.40 21.19 11.57 5.28 5.55 5.62
CPd 51.5% 96.1% 97.1% 98.7% 98.6% 98.9% 53.3% 22.2% 84.2% 98.1% 98.4% 98.4%
CP 97.1% 98.7% 98.5% 98.9% 84.2% 97.9% 98.3% 98.4%
CAD 3.92 1.28 1.25 1.19 1.09 1.05 3.89 4.64 2.53 1.10 1.07 1.06
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Table S10: Summary statistics of simulation results for the scenario of m = 200, (A3)
Λ0(t) = (0.01t)
2 and Λ∗0(t) = (0.008t)
2, and n = 1, 000.
(C1) Z1 ∼ Bernoulli(0.5), Z2 ∼ N(0, 1), (C2) Z1 ∼ Bernoulli(0.8), Z2 ∼ N(0, 1),
and Z1 ⊥ Z2, i.e., f∗(Z1, Z2) = f(Z1, Z2) and Z1 ⊥ Z2
t Λ0(t) Λ̂b0(t) Λ̂
u
0(t) Λ̂
w
0,1(t) Λ̂
w
0,2(t) Λ̂
w
0,3(t) Λ̂
w
0,4(t) Λ̂
b
0(t) Λ̂
u
0(t) Λ̂
w
0,1(t) Λ̂
w
0,2(t) Λ̂
w
0,3(t) Λ̂
w
0,4(t)
20 0.04 PBias -36.2% 1.9% 1.8% 1.7% 1.9% 1.9% -36.6% 21.5% 1.6% 1.0% 1.2% 1.2%
ESD 0.51 1.26 1.25 1.23 1.23 1.22 0.49 1.36 1.21 1.17 1.17 1.17
ASEd 0.50 1.25 1.25 1.26 1.26 1.26 0.50 1.40 1.24 1.24 1.24 1.24
ASE 1.25 1.26 1.26 1.26 1.24 1.24 1.24 1.24
sMSE 1.60 1.26 1.25 1.23 1.23 1.23 1.61 1.63 1.21 1.17 1.17 1.17
CPd 19.2% 93.1% 93.2% 93.8% 94.0% 94.0% 18.1% 95.6% 94.5% 94.7% 94.7% 94.5%
CP 93.2% 93.8% 94.0% 94.0% 94.5% 94.7% 94.7% 94.6%
40 0.16 PBias -36.8% 1.5% 1.5% 1.5% 1.6% 1.6% -37.0% 23.0% 1.9% 1.4% 1.5% 1.5%
ESD 1.47 3.14 3.11 2.98 2.98 2.98 1.43 3.58 3.37 3.21 3.19 3.20
ASEd 1.45 3.21 3.20 3.26 3.26 3.26 1.44 3.71 3.50 3.51 3.51 3.50
ASE 3.20 3.26 3.26 3.26 3.50 3.51 3.51 3.50
sMSE 6.22 3.15 3.11 2.99 2.99 2.99 6.23 5.20 3.39 3.22 3.20 3.21
CPd 3.9% 94.5% 94.9% 95.7% 96.3% 96.2% 3.3% 90.7% 95.3% 95.9% 96.2% 96.1%
CP 94.9% 95.7% 96.2% 96.2% 95.3% 95.9% 96.2% 96.1%
60 0.37 PBias -38.2% 1.4% 1.3% 1.4% 1.5% 1.5% -37.9% 24.7% 2.2% 1.7% 1.8% 1.8%
ESD 3.26 5.85 5.76 5.44 5.44 5.43 3.20 6.85 6.71 6.26 6.26 6.27
ASEd 3.18 5.97 5.94 6.14 6.14 6.14 3.20 7.08 6.94 7.01 7.01 7.00
ASE 5.94 6.14 6.15 6.16 6.94 7.01 7.01 7.01
sMSE 14.35 5.87 5.78 5.46 5.46 5.46 14.25 11.35 6.75 6.30 6.29 6.30
CPd 2.9% 95.4% 95.6% 97.2% 97.2% 97.2% 3.6% 82.8% 95.5% 97.0% 97.0% 96.8%
CP 95.6% 97.2% 97.2% 97.2% 95.5% 97.0% 97.0% 96.9%
CAD 2.82 1.15 1.14 1.10 1.10 1.10 2.82 1.99 1.23 1.17 1.17 1.17
(C3) Z1 ∼ Bernoulli(0.5), (C4) Z1 ∼ Bernoulli(0.8),
Z2|Z1=1 ∼ N(0.5, 1.2), Z2|Z1=1 ∼ N(0.5, 1.2),
and Z2|Z1=0 ∼ N(−0.5, 0.8) and Z2|Z1=0 ∼ N(−0.5, 0.8)
t Λ0(t) Λ̂b0(t) Λ̂
u
0(t) Λ̂
w
0,1(t) Λ̂
w
0,2(t) Λ̂
w
0,3(t) Λ̂
w
0,4(t) Λ̂
b
0(t) Λ̂
u
0(t) Λ̂
w
0,1(t) Λ̂
w
0,2(t) Λ̂
w
0,3(t) Λ̂
w
0,4(t)
20 0.04 PBias -36.0% 22.3% 22.2% 21.7% 15.1% 1.0% -35.9% 72.6% 44.3% 11.5% 4.8% 1.3%
ESD 0.51 1.43 1.41 1.37 1.31 1.24 0.52 1.77 1.57 1.22 1.18 1.17
ASEd 0.50 1.41 1.40 1.43 1.39 1.30 0.50 1.77 1.60 1.33 1.27 1.24
ASE 1.40 1.42 1.37 1.28 1.60 1.33 1.25 1.23
sMSE 1.59 1.71 1.69 1.65 1.46 1.24 1.60 3.53 2.44 1.32 1.20 1.17
CPd 20.7% 95.2% 95.4% 96.5% 97.3% 94.3% 20.8% 67.1% 89.8% 97.1% 96.0% 94.3%
CP 95.4% 96.2% 97.1% 94.2% 89.8% 97.0% 95.6% 94.1%
40 0.16 PBias -36.9% 11.5% 11.4% 11.0% 7.5% 0.9% -36.9% 63.9% 35.5% 7.8% 5.6% 2.9%
ESD 1.42 3.34 3.24 3.03 2.98 3.08 1.47 4.59 4.32 3.40 3.41 3.45
ASEd 1.45 3.45 3.43 3.58 3.56 3.67 1.45 4.63 4.43 3.83 3.81 3.81
ASE 3.43 3.53 3.49 3.60 4.43 3.79 3.76 3.77
sMSE 6.21 3.83 3.74 3.53 3.22 3.08 6.22 11.44 7.25 3.63 3.53 3.48
CPd 3.2% 95.7% 96.4% 97.9% 98.5% 97.2% 4.1% 36.4% 83.1% 97.7% 97.5% 97.1%
CP 96.4% 97.7% 98.1% 97.0% 83.1% 97.6% 97.4% 96.9%
60 0.37 PBias -37.9% 3.0% 2.9% 2.6% 1.4% 1.7% -38.1% 54.6% 26.5% 3.0% 4.4% 3.6%
ESD 3.23 6.02 5.79 5.36 5.40 5.82 3.22 8.39 8.15 6.39 6.50 6.70
ASEd 3.20 6.05 6.02 6.42 6.43 7.02 3.19 8.47 8.39 7.28 7.51 7.71
ASE 6.02 6.29 6.29 6.99 8.39 7.21 7.48 7.74
sMSE 14.24 6.12 5.88 5.44 5.42 5.86 14.32 21.66 12.65 6.48 6.69 6.83
CPd 3.4% 95.0% 95.9% 98.2% 97.9% 97.9% 3.5% 31.8% 88.4% 97.5% 97.9% 97.6%
CP 95.9% 97.8% 97.4% 97.8% 88.4% 97.4% 97.9% 97.7%
CAD 2.81 1.34 1.31 1.24 1.16 1.14 2.82 4.65 2.62 1.26 1.24 1.24
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Table S11: Summary statistics of simulation results for the scenario of m = 200, (A4)
Λ0(t) = (0.01t)
2 and Λ∗0(t) = (0.008t)
1.5, and n = 1, 000.
(C1) Z1 ∼ Bernoulli(0.5), Z2 ∼ N(0, 1), (C2) Z1 ∼ Bernoulli(0.8), Z2 ∼ N(0, 1),
and Z1 ⊥ Z2, i.e., f∗(Z1, Z2) = f(Z1, Z2) and Z1 ⊥ Z2
t Λ0(t) Λ̂b0(t) Λ̂
u
0(t) Λ̂
w
0,1(t) Λ̂
w
0,2(t) Λ̂
w
0,3(t) Λ̂
w
0,4(t) Λ̂
b
0(t) Λ̂
u
0(t) Λ̂
w
0,1(t) Λ̂
w
0,2(t) Λ̂
w
0,3(t) Λ̂
w
0,4(t)
20 0.04 PBias 57.4% 1.6% 1.6% 1.4% 1.6% 1.6% 58.2% 23.0% 3.0% 2.4% 2.7% 2.7%
ESD 0.90 1.20 1.20 1.18 1.17 1.17 0.91 1.39 1.22 1.18 1.18 1.18
ASEd 0.88 1.22 1.21 1.22 1.22 1.22 0.89 1.37 1.20 1.20 1.20 1.20
ASE 1.21 1.22 1.22 1.22 1.20 1.20 1.20 1.20
sMSE 2.57 1.21 1.20 1.18 1.17 1.17 2.61 1.69 1.22 1.18 1.18 1.18
CPd 17.1% 94.4% 94.3% 94.8% 95.3% 95.1% 16.3% 94.4% 93.9% 94.1% 94.4% 94.3%
CP 94.3% 94.8% 95.2% 95.0% 93.9% 94.1% 94.5% 94.3%
40 0.16 PBias 11.4% 1.1% 1.1% 0.9% 1.1% 1.1% 11.3% 23.3% 2.3% 1.8% 2.0% 2.0%
ESD 2.01 2.96 2.94 2.77 2.76 2.75 2.04 3.46 3.20 3.00 3.00 3.00
ASEd 2.01 3.05 3.03 3.09 3.10 3.10 2.01 3.53 3.23 3.24 3.25 3.23
ASE 3.03 3.09 3.10 3.10 3.23 3.24 3.25 3.23
sMSE 2.75 2.97 2.94 2.77 2.77 2.76 2.75 5.16 3.22 3.02 3.02 3.02
CPd 87.3% 95.8% 96.0% 96.8% 97.0% 97.0% 87.6% 88.5% 95.1% 96.0% 96.4% 96.2%
CP 96.0% 96.8% 96.9% 97.0% 95.1% 96.0% 96.4% 96.2%
60 0.37 PBias -10.1% 1.3% 1.3% 1.2% 1.3% 1.3% -10.4% 24.6% 2.3% 1.8% 1.9% 1.9%
ESD 3.82 5.51 5.43 5.07 5.07 5.06 3.87 6.55 6.23 5.76 5.76 5.76
ASEd 3.82 5.65 5.62 5.82 5.82 5.82 3.81 6.70 6.30 6.39 6.39 6.37
ASE 5.62 5.82 5.83 5.84 6.30 6.39 6.39 6.38
sMSE 5.32 5.53 5.45 5.09 5.09 5.08 5.42 11.13 6.29 5.80 5.80 5.80
CPd 79.2% 95.4% 95.1% 97.5% 97.7% 97.6% 78.0% 80.5% 95.1% 96.8% 96.9% 96.9%
CP 95.1% 97.4% 97.7% 97.6% 95.1% 96.8% 96.9% 97.0%
CAD 1.31 1.10 1.09 1.04 1.04 1.03 1.32 1.98 1.17 1.09 1.09 1.09
(C3) Z1 ∼ Bernoulli(0.5), (C4) Z1 ∼ Bernoulli(0.8),
Z2|Z1=1 ∼ N(0.5, 1.2), Z2|Z1=1 ∼ N(0.5, 1.2),
and Z2|Z1=0 ∼ N(−0.5, 0.8) and Z2|Z1=0 ∼ N(−0.5, 0.8)
t Λ0(t) Λ̂b0(t) Λ̂
u
0(t) Λ̂
w
0,1(t) Λ̂
w
0,2(t) Λ̂
w
0,3(t) Λ̂
w
0,4(t) Λ̂
b
0(t) Λ̂
u
0(t) Λ̂
w
0,1(t) Λ̂
w
0,2(t) Λ̂
w
0,3(t) Λ̂
w
0,4(t)
20 0.04 PBias 58.3% 24.1% 24.1% 23.7% 16.9% 2.7% 57.8% 72.9% 44.3% 11.5% 4.7% 1.4%
ESD 0.87 1.36 1.35 1.30 1.25 1.17 0.88 1.68 1.47 1.15 1.09 1.09
ASEd 0.89 1.38 1.38 1.41 1.37 1.27 0.89 1.72 1.51 1.25 1.19 1.16
ASE 1.38 1.40 1.35 1.25 1.51 1.25 1.17 1.14
sMSE 2.60 1.70 1.69 1.64 1.44 1.17 2.58 3.49 2.37 1.25 1.11 1.09
CPd 16.1% 94.4% 94.4% 96.1% 97.1% 95.4% 16.6% 62.3% 87.8% 97.0% 96.4% 95.5%
CP 94.4% 95.8% 96.8% 95.2% 87.8% 97.0% 96.1% 95.3%
40 0.16 PBias 11.4% 12.9% 12.8% 12.6% 8.9% 2.3% 10.9% 63.9% 35.3% 7.4% 5.2% 2.6%
ESD 2.01 3.19 3.11 2.85 2.82 2.90 2.03 4.18 3.84 3.00 2.99 3.07
ASEd 2.01 3.31 3.29 3.45 3.44 3.53 2.00 4.39 4.05 3.51 3.50 3.48
ASE 3.29 3.39 3.36 3.45 4.05 3.47 3.44 3.44
sMSE 2.75 3.83 3.75 3.51 3.18 2.93 2.71 11.29 6.95 3.24 3.10 3.10
CPd 87.9% 95.0% 95.3% 97.8% 98.1% 97.7% 87.9% 29.3% 80.2% 98.5% 98.0% 96.6%
CP 95.3% 97.3% 97.9% 97.6% 80.2% 98.4% 97.9% 96.5%
60 0.37 PBias -10.1% 3.7% 3.7% 3.5% 2.2% 2.6% -10.4% 54.8% 26.4% 2.9% 4.2% 3.5%
ESD 3.88 5.68 5.44 4.92 4.98 5.32 3.83 7.94 7.39 5.77 5.91 6.18
ASEd 3.82 5.76 5.73 6.15 6.17 6.76 3.82 8.05 7.61 6.66 6.90 7.09
ASE 5.73 6.01 6.03 6.73 7.61 6.58 6.87 7.12
sMSE 5.35 5.85 5.60 5.09 5.05 5.41 5.39 21.58 12.17 5.87 6.11 6.32
CPd 79.2% 95.4% 96.3% 98.6% 98.4% 98.7% 79.2% 24.2% 85.3% 97.1% 97.5% 97.1%
CP 96.3% 98.4% 98.3% 98.7% 85.3% 97.0% 97.5% 97.2%
CAD 1.32 1.34 1.31 1.23 1.13 1.08 1.31 4.67 2.59 1.15 1.12 1.12
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Figure S1: Minimal coverage probability of the proposed weighted estimator Λ̂w0,4(t).
Minimal coverage probability is defined as the minimum of coverage probabilities at
the three time points, 20, 40, and 60. Corr: Pearson correlation coefficient between
risk score for event of interest and Tc, i.e., corr(β
T
0Z, Tc). Horizontal axis: probability
of observing the event of interest; vertical axis: ratio between probability of observing
the event of competing risk and probability of observing the event of interest.
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Figure S2: Calibration plots of model-based and empirical 10-year absolute risk. Solid
line: average model-based absolute risk in each risk group; Dotdash line (cross): the
95% CIs (point estimates) of empirical absolute risk in each risk group.
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Table S12: Real data based simulation results in the presence of competing risks
(UKB cohorts as the target populations).
UKB England UKB Scotland
t Λ0(t)(10−3) Λ̂b0(t) Λ̂
u
0(t) Λ̂
w
0,p(t) Λ̂
w
0,a(t) Λ0(t)(10
−3) Λ̂b0(t) Λ̂
u
0(t) Λ̂
w
0,p(t) Λ̂
w
0,a(t)
5 1.2 PBias -45.4% 17.7% -0.6% -0.1% 0.4 PBias 61.3% 16.9% 1.3% 2.4%
Bias -0.47 0.19 -0.01 0.00 Bias 0.22 0.06 0.00 0.01
ESD 0.11 0.14 0.10 0.10 ESD 0.11 0.18 0.15 0.16
ASE 0.10 0.14 0.09 0.09 ASE 0.10 0.17 0.15 0.15
sMSE 0.49 0.23 0.10 0.10 sMSE 0.24 0.19 0.15 0.16
CP 2.8% 76.4% 93.5% 93.9% CP 45.2% 93.3% 91.1% 91.1%
10 3.6 PBias -5.5% 17.6% -0.7% -0.2% 2.2 PBias 60.0% 14.7% -0.9% 0.2%
Bias -0.18 0.59 -0.02 -0.01 Bias 1.20 0.30 -0.02 0.00
ESD 0.37 0.39 0.25 0.24 ESD 0.37 0.49 0.41 0.41
ASE 0.36 0.38 0.24 0.24 ASE 0.36 0.48 0.39 0.40
sMSE 0.41 0.71 0.25 0.24 sMSE 1.26 0.58 0.41 0.41
CP 88.2% 69.3% 93.8% 94.5% CP 4.4% 94.2% 93.4% 93.9%
15 7.1 PBias 30.7% 17.6% -0.6% -0.1% 5.9 PBias 59.3% 14.8% -0.8% 0.3%
Bias 2.06 1.18 -0.04 -0.01 Bias 3.26 0.81 -0.05 0.01
ESD 0.91 0.76 0.48 0.46 ESD 0.88 1.03 0.81 0.82
ASE 0.88 0.74 0.45 0.45 ASE 0.88 1.02 0.79 0.80
sMSE 2.25 1.41 0.49 0.46 sMSE 3.38 1.31 0.81 0.82
CP 33.2% 66.6% 93.3% 94.4% CP 1.1% 91.6% 93.4% 93.9%
20 11.3 PBias 64.2% 17.1% -1.1% -0.6% 11.9 PBias 59.0% 14.6% -1.0% 0.1%
Bias 7.01 1.87 -0.12 -0.06 Bias 6.66 1.65 -0.11 0.01
ESD 1.77 1.26 0.81 0.77 ESD 1.75 1.98 1.53 1.55
ASE 1.73 1.22 0.76 0.75 ASE 1.73 1.98 1.52 1.54
sMSE 7.23 2.25 0.82 0.77 sMSE 6.88 2.57 1.53 1.55
CP 0.4% 69.2% 92.9% 93.9% CP 0.7% 91.8% 93.8% 94.5%
CAD 29.6 14.7 4.8 4.6 CAD 38.6 12.9 8.3 8.4
NOTE: Λ̂b0(t), the WHI estimator; Λ̂
u
0(t), the unweighted estimator; Λ̂
p
0(t), the weighted estimator with the same
constrain as in the example; Λ̂a0(t), the weighted estimator with the constrain of all risk factor prevalences; PBias,
the relative bias; ESD, the empirical standard deviation (×1000) of the 2000 estimates; ASE, the mean of the
asymptotic-based standard error (×1000); sMSE, the square root of mean squared error (×1000); CP, the coverage
probability of a 95% confidence interval for Λ0(t); CAD, the average cumulative absolute deviation between the
estimates and the true values across a time range of one through twenty (×1000).
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Table S13: Real data based simulation results in the presence of competing risks
(PLCO cohorts as the target populations).
PLCO intervention cohort PLCO control cohort
t Λ0(t)(10−3) Λ̂b0(t) Λ̂
u
0(t) Λ̂
w
0,p(t) Λ̂
w
0,a(t) Λ0(t)(10
−3) Λ̂b0(t) Λ̂
u
0(t) Λ̂
w
0,p(t) Λ̂
w
0,a(t)
5 0.1 PBias 771.6% 23.7% 2.1% 3.9% 0.3 PBias 47.4% -0.1% 1.1% 2.5%
Bias 0.51 0.02 0.00 0.00 Bias 0.18 0.00 0.00 0.01
ESD 0.11 0.05 0.05 0.05 ESD 0.10 0.13 0.12 0.13
ASE 0.10 0.05 0.04 0.04 ASE 0.10 0.12 0.12 0.12
sMSE 0.52 0.05 0.05 0.05 sMSE 0.21 0.13 0.12 0.13
CP 0.0% 86.8% 77.0% 78.2% CP 61.2% 91.7% 92.2% 92.7%
10 0.8 PBias 515.2% 16.2% 1.2% 2.1% 1.6 PBias 58.2% -2.3% -1.1% 0.3%
Bias 2.67 0.08 0.01 0.01 Bias 1.17 -0.05 -0.02 0.01
ESD 0.36 0.16 0.14 0.14 ESD 0.36 0.33 0.30 0.31
ASE 0.36 0.16 0.13 0.13 ASE 0.36 0.32 0.30 0.30
sMSE 2.70 0.18 0.14 0.14 sMSE 1.23 0.33 0.31 0.31
CP 0.0% 95.3% 93.5% 93.6% CP 5.0% 92.2% 93.3% 93.8%
15 2.7 PBias 402.6% 13.9% -1.1% -0.2% 4.1 PBias 64.6% -2.3% -1.1% 0.3%
Bias 7.02 0.24 -0.02 0.00 Bias 3.43 -0.12 -0.06 0.02
ESD 0.88 0.33 0.28 0.29 ESD 0.88 0.65 0.56 0.58
ASE 0.88 0.33 0.27 0.28 ASE 0.88 0.64 0.55 0.56
sMSE 7.07 0.41 0.29 0.29 sMSE 3.54 0.66 0.56 0.58
CP 0.0% 92.5% 92.9% 93.7% CP 0.6% 92.4% 94.0% 94.5%
20 6.3 PBias 335.5% 14.1% -0.9% 0.0% 7.9 PBias 69.4% -2.4% -1.2% 0.2%
Bias 13.83 0.58 -0.04 0.00 Bias 7.35 -0.25 -0.12 0.03
ESD 1.74 0.61 0.52 0.52 ESD 1.72 1.12 0.92 0.95
ASE 1.73 0.61 0.50 0.51 ASE 1.73 1.12 0.91 0.95
sMSE 13.94 0.84 0.52 0.52 sMSE 7.55 1.15 0.92 0.95
CP 0.0% 89.1% 93.2% 94.2% CP 0.2% 92.6% 93.8% 94.5%
25 12.1 PBias 289.4% 13.9% -1.1% -0.2% 13.4 PBias 73.1% -2.8% -1.6% -0.2%
Bias 23.27 1.12 -0.08 -0.01 Bias 13.21 -0.50 -0.28 -0.03
ESD 2.97 1.07 0.91 0.90 ESD 2.98 1.84 1.47 1.53
ASE 2.97 1.08 0.87 0.89 ASE 2.98 1.82 1.45 1.50
sMSE 23.46 1.55 0.91 0.90 sMSE 13.54 1.91 1.50 1.53
CP 0.0% 87.1% 93.5% 94.6% CP 0.0% 92.2% 93.5% 94.4%
30 20.7 PBias 255.5% 13.5% -1.5% -0.6% 20.6 PBias 76.2% -2.9% -1.7% -0.3%
Bias 35.47 1.87 -0.20 -0.08 Bias 21.31 -0.82 -0.49 -0.10
ESD 4.73 1.85 1.57 1.55 ESD 4.71 2.84 2.28 2.37
ASE 4.71 1.84 1.49 1.52 ASE 4.71 2.83 2.26 2.35
sMSE 35.78 2.63 1.58 1.55 sMSE 21.82 2.96 2.33 2.37
CP 0.0% 87.4% 92.3% 93.4% CP 0.0% 92.3% 93.1% 94.4%
CAD 320.9 17.2 10.5 10.4 CAD 177.1 22.4 18.1 18.4
NOTE: Λ̂b0(t), the WHI estimator; Λ̂
u
0(t), the unweighted estimator; Λ̂
p
0(t), the weighted estimator with the same
constrain as in the example; Λ̂a0(t), the weighted estimator with the constrain of all risk factor prevalences; PBias,
the relative bias; ESD, the empirical standard deviation (×1000) of the 2000 estimates; ASE, the mean of the
asymptotic-based standard error (×1000); sMSE, the square root of mean squared error (×1000); CP, the coverage
probability of a 95% confidence interval for Λ0(t); CAD, the average cumulative absolute deviation between the
estimates and the true values across a time range of one through thirty (×1000).
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